https://curecurrent.com/trials/multicenter-cardiac-decision-impact-study-in-people-with-breast-cancer-26001https://curecurrent.com/trials/sentinel-node-biopsy-in-breast-cancer-omission-of-axillary-clearance-after-macrometastases-a-randomized-trial-26002https://curecurrent.com/trials/real-world-treatment-patterns-and-outcomes-in-her2-altered-metastatic-breast-cancer-patients-in-the-united-states-26003https://curecurrent.com/trials/study-to-evaluate-the-feasibility-of-twice-daily-use-of-topical-azelaic-acid-in-breast-cancer-patients-undergoing-radiat-26004https://curecurrent.com/trials/identifying-and-caring-for-individuals-with-inherited-cancer-syndrome-26005https://curecurrent.com/trials/understanding-and-addressing-disparities-in-cancer-therapy-induced-inflammation-and-associated-endothelial-dysfunction-26006https://curecurrent.com/trials/phase-ii-lenvatinib-and-pembrolizumab-in-endocrine-resistant-breast-cancer-with-letrozole-26007https://curecurrent.com/trials/a-study-of-the-efficacy-safety-and-pharmacokinetics-of-rph-051-and-perjeta-in-combination-with-trastuzumab-and-docetaxel-26008https://curecurrent.com/trials/cediranib-maleate-and-olaparib-in-treating-patients-with-recurrent-ovarian-fallopian-tube-or-peritoneal-cancer-or-recurr-26009https://curecurrent.com/trials/study-to-evaluate-sacituzumab-govitecan-in-combination-with-talazoparib-in-patients-with-metastatic-breast-cancer-26010https://curecurrent.com/trials/study-of-adcs-combined-with-adebrelimab-in-her2-negative-advanced-breast-cancer-26011https://curecurrent.com/trials/advancing-patient-care-for-lymphatic-pain-and-lymphedema-26012https://curecurrent.com/trials/tai-chi-exercise-reduces-fatigue-in-breast-cancer-patients-undergoing-chemotherapy-26013https://curecurrent.com/trials/integrated-molecular-profiling-in-advanced-cancers-trial-26014https://curecurrent.com/trials/high-cannabidiol-plant-extract-brc-001-to-improve-aromatase-inhibitor-induced-arthralgia-in-women-with-breast-cancer-26015https://curecurrent.com/trials/shield-surveillance-of-hr-her2-implementing-esr1m-long-term-monitoring-and-detection-in-1l-abc-26016https://curecurrent.com/trials/mobile-self-management-training-for-lymphedema-prevention-26017https://curecurrent.com/trials/progress-precision-oncology-using-genomic-reflexive-evaluations-for-study-selection-and-survival-26018https://curecurrent.com/trials/repurposing-riluzole-for-cancer-related-cognitive-impairment-a-pilot-trial-26019https://curecurrent.com/trials/neoadjuvant-high-intensity-focused-ultrasound-hifu-combined-with-toripalimab-and-chemotherapy-for-er-positive-her2-negat-26020https://curecurrent.com/trials/olaparib-as-adjuvant-treatment-in-patients-with-germline-brca-mutated-high-risk-her2-negative-primary-breast-cancer-26021https://curecurrent.com/trials/wide-field-oct-ai-for-positive-margin-rates-in-breast-conservation-surgery-26022https://curecurrent.com/trials/screening-for-bcrl-in-targeted-therapy-for-breast-cancer-26023https://curecurrent.com/trials/real-world-study-of-pyrotinib-containing-regimens-of-advanced-her2-positive-breast-cancer-26024https://curecurrent.com/trials/atezolizumab-plus-tivozanib-in-immunologically-cold-tumor-types-26025https://curecurrent.com/trials/real-world-evaluation-of-patient-outcomes-and-experiences-with-ribociclib-early-adopters-26026https://curecurrent.com/trials/cdk4-6-inhibitors-combined-with-endocrine-therapy-for-neoadjuvant-treatment-26027https://curecurrent.com/trials/pre-op-pembro-radiation-therapy-in-breast-cancer-p-rad-26028https://curecurrent.com/trials/testing-a-new-imaging-agent-to-identify-cancer-26029https://curecurrent.com/trials/self-reported-pain-in-women-while-undergoing-treatment-for-non-metastatic-breast-cancer-26030https://curecurrent.com/trials/a-phase-iii-randomised-study-to-evaluate-dato-dxd-and-durvalumab-for-neoadjuvant-adjuvant-treatment-of-triple-negative-o-26031https://curecurrent.com/trials/testing-the-safety-of-the-combination-of-anti-cancer-drugs-cx-5461-pidnarulex-and-trastuzumab-deruxtecan-t-dxd-for-human-26032https://curecurrent.com/trials/a-phase-1-study-of-68ga-r11228-and-177lu-r11228-in-breast-cancer-26033https://curecurrent.com/trials/early-intervention-26034https://curecurrent.com/trials/evaluating-in-vivo-parp-1-expression-with-18f-fluorthanatrace-positron-emission-tomography-pet-ct-in-breast-cancer-26035https://curecurrent.com/trials/a-phase-1-2-trial-of-tc-510-in-patients-with-advanced-mesothelin-expressing-cancer-26036https://curecurrent.com/trials/fast-her-fasting-effects-on-breast-cancer-treatment-26037https://curecurrent.com/trials/an-open-label-bayesian-adaptive-phase-ii-clinical-study-in-hr-her2-advanced-breast-cancer-after-progression-on-standard-26038https://curecurrent.com/trials/clinical-trial-of-tqb3126-for-safety-tolerability-pharmacokinetics-and-preliminary-efficacy-in-breast-cancer-subjects-26039https://curecurrent.com/trials/effects-metabolic-mechanisms-and-predictors-of-response-to-acupuncture-in-treating-psychoneurological-symptoms-among-bre-26040https://curecurrent.com/trials/a-cohort-study-of-combined-cryoablation-and-thermal-ablation-for-non-surgical-treatment-of-breast-cancer-patients-26041https://curecurrent.com/trials/a-study-of-parg-inhibitor-ide161-in-participants-with-advanced-solid-tumors-26042https://curecurrent.com/trials/ctdna-guided-de-escalation-of-adjuvant-chemotherapy-with-dalpiciclib-in-hr-positive-her2-negative-breast-cancer-26043https://curecurrent.com/trials/exploring-the-efficacy-and-feasibility-of-the-lymphatech-scanner-for-breast-cancer-related-lymphedema-screening-26044https://curecurrent.com/trials/a-phase-ii-clinical-study-of-multimodal-ablation-combined-with-systemic-drug-therapy-for-advanced-solid-tumors-26045https://curecurrent.com/trials/pembrolizumab-paclitaxel-bevacizumab-for-triple-negative-breast-cancer-26046https://curecurrent.com/trials/study-of-stereotactic-radiosurgery-with-olaparib-followed-by-durvalumab-and-physician-s-choice-systemic-therapy-in-subje-26047https://curecurrent.com/trials/a-study-to-understand-about-the-study-medicine-palbociclib-in-breast-cancer-patients-after-it-is-out-in-the-japanese-mar-26048https://curecurrent.com/trials/electroacupuncture-for-chemotherapy-induced-gi-symptom-clusters-in-breast-cancer-26049https://curecurrent.com/trials/a-study-of-antibiotic-delivery-to-prevent-infection-after-breast-tissue-expander-placement-26050https://curecurrent.com/trials/safety-and-efficacy-of-cea-targeted-car-t-therapy-for-relapsed-refractory-cea-cancer-26051https://curecurrent.com/trials/trial-of-therapies-with-it-cdc1s-combined-w-it-trastuzamab-for-her-or-it-nivolumab-for-her-bc-lmd-26052https://curecurrent.com/trials/bupropion-hydrochloride-in-improving-sexual-desire-in-women-with-breast-or-gynecologic-cancer-26053https://curecurrent.com/trials/access-my-breast-cancer-care-app-26054https://curecurrent.com/trials/study-of-quality-of-life-and-hormone-levels-in-premenopausal-participants-with-early-breast-cancer-receiving-triptorelin-26055https://curecurrent.com/trials/physical-activity-for-adults-in-the-ontario-breast-screening-program-26056https://curecurrent.com/trials/a-phase-2-study-of-t-dxd-in-patients-with-selected-her2-expressing-tumors-26057https://curecurrent.com/trials/study-of-the-molecular-features-of-postmenopausal-women-with-hr-her2-negative-abc-on-first-line-treatment-with-ribocicli-26058https://curecurrent.com/trials/olaparib-trastuzumab-pertuzumab-neoadjuvant-for-elderly-her2-breast-cancer-26059https://curecurrent.com/trials/testing-whether-treating-breast-cancer-metastases-with-surgery-or-high-dose-radiation-improves-survival-26060https://curecurrent.com/trials/tucatinib-trastuzumab-eribulin-in-her2-mbc-26061https://curecurrent.com/trials/4fmfes-pet-imaging-of-er-advanced-breast-cancers-26062https://curecurrent.com/trials/interpretations-and-predictions-of-patient-reported-outcomes-by-breast-cancer-patients-26063https://curecurrent.com/trials/tislelizumab-in-combination-with-bevacizumab-and-capecitabine-in-advanced-solid-tumors-with-evaluation-in-immunotherapy-26064https://curecurrent.com/trials/nab-paclitaxel-in-treating-older-patients-with-locally-advanced-or-metastatic-breast-cancer-26065https://curecurrent.com/trials/supervised-aerobic-training-during-or-after-chemotherapy-for-operable-breast-cancer-26066https://curecurrent.com/trials/a-study-to-understand-the-use-of-palbociclib-in-canadian-patients-with-breast-cancer-that-has-spread-to-other-organs-26067https://curecurrent.com/trials/augmented-reality-icg-fluorescence-second-look-for-residual-nodal-disease-after-axillary-dissection-in-breast-cancer-26068https://curecurrent.com/trials/patient-centered-clinical-decision-support-for-hereditary-cancer-syndromes-26069https://curecurrent.com/trials/a-phase-2-study-of-zanidatamab-in-patients-with-her2-expressing-tumors-26070https://curecurrent.com/trials/study-of-sacituzumab-govitecan-sg-in-japanese-participants-with-advanced-solid-tumors-26071https://curecurrent.com/trials/opioid-dispensing-device-for-post-operative-pain-in-cancer-patients-26072https://curecurrent.com/trials/predicting-response-to-immunochemotherapy-in-early-triple-negative-breast-cancer-26073https://curecurrent.com/trials/monitoring-plasma-tumor-dna-in-early-stage-breast-cancer-26074https://curecurrent.com/trials/chinese-medicinal-component-relieves-cipn-and-mitochondria-function-26075https://curecurrent.com/trials/bariatric-surgery-after-breast-cancer-treatment-bats-26076https://curecurrent.com/trials/robotic-assisted-versus-endoscopic-assisted-axillary-lymph-node-dissection-in-breast-cancer-26077https://curecurrent.com/trials/stress-reduction-through-acupuncture-26078https://curecurrent.com/trials/a-phase-1-study-of-pegilodecakin-ly3500518-in-participants-with-advanced-solid-tumors-26079https://curecurrent.com/trials/multimodal-exercise-and-education-program-in-metastatic-breast-cancermostrar-m-s-l-neas-26080https://curecurrent.com/trials/a-study-of-a-decision-tool-for-people-considering-breast-reconstruction-surgery-26081https://curecurrent.com/trials/a-study-to-learn-more-about-how-well-elinzanetant-works-and-how-safe-it-is-compared-to-placebo-for-the-treatment-of-hot-26082https://curecurrent.com/trials/study-to-assess-the-safety-of-alpelisib-plus-fulvestrant-in-men-and-post-menopausal-women-with-hr-positive-her2-negative-26083https://curecurrent.com/trials/neoadjuvant-nivolumab-and-chemotherapy-in-patients-with-localized-triple-negative-breast-cancer-26084https://curecurrent.com/trials/impact-of-physical-exercise-on-lymphedema-related-to-breast-cancer-assessment-using-thermography-26085https://curecurrent.com/trials/a-study-of-tqb2102-for-injection-in-patients-with-recurrent-metastatic-breast-cancer-26086https://curecurrent.com/trials/a-randomized-trial-evaluating-personalized-vs-guideline-based-well-follow-up-strategies-for-patients-with-early-stage-br-26087https://curecurrent.com/trials/evaluating-omission-of-granulocyte-colony-stimulating-factors-in-breast-cancer-patients-receiving-paclitaxel-portion-of-26088https://curecurrent.com/trials/ctdna-guided-intraventricular-therapy-for-cns-malignancies-26089https://curecurrent.com/trials/evaluating-the-response-guided-therapy-with-neoadjuvant-endocrine-therapy-to-optimize-adjuvant-treatment-in-premenopausa-26090https://curecurrent.com/trials/the-e-consult-application-for-patients-with-breast-cancer-interest-in-empathy-and-empowerment-of-patients-26091https://curecurrent.com/trials/artificial-intelligence-model-guided-neoadjuvant-anti-her2-targeted-therapy-26092https://curecurrent.com/trials/efficacy-and-safety-of-ribociclib-in-pre-and-postmenopausal-chinese-women-with-hr-positive-her2-negative-advanced-breast-26093https://curecurrent.com/trials/pilot-study-of-neoadjuvant-chemotherapy-combined-with-immunotherapy-and-multimodal-thermal-therapy-for-her2-negative-bre-26094https://curecurrent.com/trials/z-endoxifen-for-the-treatment-of-premenopausal-women-with-er-her2-breast-cancer-26095https://curecurrent.com/trials/endoscopic-assisted-latissimus-dorsi-musculocutaneous-flap-for-breast-reconstruction-26096https://curecurrent.com/trials/her-tempo-real-world-treatment-related-outcomes-on-t-dxd-in-canada-26097https://curecurrent.com/trials/precision-medicine-in-action-phase-ii-trial-of-response-adaptive-ablative-pre-operative-spbi-raps-and-non-operative-sent-26098https://curecurrent.com/trials/neoadjuvant-her2-targeted-therapy-and-immunotherapy-with-pembrolizumab-iit2018-04-mcarthur-neohp-26099https://curecurrent.com/trials/adaptation-and-pilot-testing-of-a-mindfulness-based-insomnia-and-symptom-management-intervention-for-women-with-breast-c-26100https://curecurrent.com/trials/assessment-of-topical-minoxidil-on-intraoperative-flap-perfusion-and-cutaneous-flap-viability-in-breast-recon-26101https://curecurrent.com/trials/does-anesthesia-technique-impact-on-the-long-term-outcome-5-and-10-years-after-the-first-intervention-in-primary-breast-26102https://curecurrent.com/trials/quantifyher-quantitative-immunofluorescence-and-or-rt-qpcr-for-measuring-her2-in-her2-low-metastatic-breast-cancer-26103https://curecurrent.com/trials/research-on-ai-models-for-predicting-breast-cancer-treatment-effectiveness-to-guide-her-2-targeted-adc-therapy-26104https://curecurrent.com/trials/locally-ablative-therapy-in-oligo-progressive-solid-tumors-valorous-26105https://curecurrent.com/trials/web-based-pain-coping-skills-training-for-breast-cancer-survivors-with-ai-associated-arthralgia-26106https://curecurrent.com/trials/kumorixilib-plus-capecitabine-and-letrozole-for-neoadjuvant-treatment-of-hr-positive-her2-negative-breast-cancer-26107https://curecurrent.com/trials/study-of-naxitamab-and-sacituzumab-govitecan-in-patients-with-metastatic-triple-negative-breast-cancer-tnbc-26108https://curecurrent.com/trials/performance-of-anthracycline-free-neoadjuvant-chemoimmunotherapy-in-early-triple-negative-breast-cancer-26109https://curecurrent.com/trials/clinical-study-of-local-and-systemic-biological-impact-of-glp1-gip-receptor-agonists-in-patients-with-breast-cancer-the-26110https://curecurrent.com/trials/the-impact-of-whatsapp-based-ex-plissit-model-sexual-counseling-on-the-sexual-lives-of-breast-cancer-survivors-26111https://curecurrent.com/trials/acolbifene-versus-low-dose-tamoxifen-for-the-prevention-of-breast-cancer-in-premenopausal-women-at-high-risk-for-develop-26112https://curecurrent.com/trials/initial-staging-of-lobular-breast-carcinoma-head-to-head-comparison-of-68ga-fapi-46-and-18f-fdg-pet-ct-26113https://curecurrent.com/trials/a-phase-iii-study-of-kn026-in-combination-with-hb1801-carboplatin-as-neoadjuvant-treatment-for-early-or-locally-advanced-26114https://curecurrent.com/trials/first-in-human-study-of-tersolisib-stx-478-as-monotherapy-and-in-combination-with-other-antineoplastic-agents-in-partici-26115https://curecurrent.com/trials/surgery-vs-no-surgery-for-primary-tumor-in-de-novo-stage-iv-breast-cancer-with-solitary-bone-metastases-26116https://curecurrent.com/trials/nab-paclitaxel-and-alpelisib-for-the-treatment-of-anthracycline-refractory-triple-negative-breast-cancer-with-pik3ca-or-26117https://curecurrent.com/trials/real-world-patient-reported-outcomes-in-chinese-her2-ebc-patients-receiving-neo-adjuvant-anti-her2-based-therapy-26118https://curecurrent.com/trials/a-first-in-human-study-to-learn-how-safe-the-study-drug-bay3375968-an-anti-ccr8-antibody-is-when-given-alone-or-in-combi-26119https://curecurrent.com/trials/trial-to-evaluate-the-impact-of-various-interventions-to-increase-the-uptake-of-surveillance-mammography-in-eligible-wom-26120https://curecurrent.com/trials/abemaciclib-dose-escalation-to-maintain-intensity-ade-mi-26121https://curecurrent.com/trials/oral-fecal-and-intratumoral-microbiome-atlas-in-colombian-patients-with-advanced-solid-tumors-receiving-first-line-immun-26122https://curecurrent.com/trials/comparing-a-single-dose-vs-twice-yearly-zoledronate-in-patients-with-early-stage-breast-cancer-react-zol-26123https://curecurrent.com/trials/cryoablation-of-low-risk-small-breast-cancer-ice3-trial-26124https://curecurrent.com/trials/palbociclib-in-combination-with-bicalutamide-for-the-treatment-of-ar-metastatic-breast-cancer-mbc-26125https://curecurrent.com/trials/brain-health-in-breast-cancer-survivors-26126https://curecurrent.com/trials/device-validation-of-augmented-reality-icg-fluorescence-imaging-for-sentinel-lymph-node-detection-in-breast-cancer-26127https://curecurrent.com/trials/community-gateway-to-health-study-26128https://curecurrent.com/trials/a-phase-iiib-study-to-evaluate-the-use-of-capivasertib-in-combination-with-fulvestrant-in-patients-with-advanced-breast-26129https://curecurrent.com/trials/navigation-intervention-for-adolescent-and-young-adult-cancer-survivors-26130https://curecurrent.com/trials/study-of-68ga-r10602-26131https://curecurrent.com/trials/genetic-counseling-patient-preference-intervention-versus-conventional-genetic-counseling-for-women-at-elevated-risk-for-26132https://curecurrent.com/trials/efficacy-and-safety-of-utidelone-capsule-and-utidelone-injection-in-patients-with-her-2-negative-advanced-breast-cancer-26133https://curecurrent.com/trials/a-study-of-sigvotatug-vedotin-in-advanced-solid-tumors-26134https://curecurrent.com/trials/predictive-model-of-axillary-nodal-status-after-neoadjuvant-chemotherapy-in-breast-cancer-patients-26135https://curecurrent.com/trials/c7r-gd2-cart-cells-for-patients-with-relapsed-or-refractory-neuroblastoma-and-other-gd2-positive-cancers-gail-n-26136https://curecurrent.com/trials/fluorocholine-pet-mr-in-breast-cancer-26137https://curecurrent.com/trials/first-in-human-study-of-oki-219-in-advanced-solid-tumors-and-advanced-breast-cancer-26138https://curecurrent.com/trials/quality-of-life-improvement-during-chemotherapy-26139https://curecurrent.com/trials/treatment-monitoring-of-patients-receiving-cdk-4-6-inhibitors-for-hormone-receptor-hr-positive-her2-negative-metastatic-26140https://curecurrent.com/trials/rwe-non-interventional-prospective-study-of-ribociclib-effectiveness-and-safety-in-patients-with-hr-her2-early-breast-ca-26141https://curecurrent.com/trials/pg2-breast-cancer-evaluation-in-adjuvant-medicine-survival-study-26142https://curecurrent.com/trials/pectoral-nerve-block-versus-paravertebral-block-in-the-incidence-of-chronic-pain-after-breast-cancer-surgery-26143https://curecurrent.com/trials/increasing-screening-for-cancer-using-ehr-nudges-26144https://curecurrent.com/trials/a-phase-2-study-of-eribulin-followed-by-ac-as-preoperative-therapy-for-her2-negative-inflammatory-breast-cancer-26145https://curecurrent.com/trials/extracellular-vesicles-in-breast-cancer-patientsin-undergone-neoadjuvant-chemotherapy-26146https://curecurrent.com/trials/capecitabine-in-combination-with-cemiplimab-in-patient-with-metastatic-breast-cancer-26147https://curecurrent.com/trials/nir-device-for-assessment-of-skin-flap-perfusion-in-breast-surgery-a-pilot-interventional-study-26148https://curecurrent.com/trials/trade-dose-escalation-tolerability-of-abemaciclib-in-hr-her2-early-stage-breast-cancer-26149https://curecurrent.com/trials/sapanisertib-and-serabelisib-piktor-in-various-combinations-in-patients-with-hr-her2-advanced-metastatic-breast-cancer-26150https://curecurrent.com/trials/to-assess-safety-and-efficacy-of-agents-targeting-dna-damage-repair-with-olaparib-versus-olaparib-monotherapy-26151https://curecurrent.com/trials/to-describe-how-well-vinorelbine-given-orally-works-in-patients-with-a-breast-cancer-after-2-years-of-treatment-26152https://curecurrent.com/trials/reduction-of-physical-inactivity-facing-the-cancer-26153https://curecurrent.com/trials/technique-of-per-operative-radiotherapy-rpo-by-papillon-tm-in-localized-breast-cancer-26154https://curecurrent.com/trials/antthracycline-induced-inflammation-and-oxidative-stress-10-year-follow-up-26155https://curecurrent.com/trials/use-of-cognitive-stimulation-software-for-patients-over-the-age-of-70-followed-for-breast-cancer-cog-tab-age-feasibility-26156https://curecurrent.com/trials/a-pilot-study-to-evaluate-the-effectiveness-of-focused-massage-on-pain-mobility-and-quality-of-life-during-radiation-tre-26157https://curecurrent.com/trials/pharmacokinetic-study-of-skeletal-muscle-area-based-paclitaxel-infusion-in-patients-with-cancer-26158https://curecurrent.com/trials/management-of-cognitive-difficulties-after-cancer-treatments-in-women-treated-for-breast-cancer-feasibility-study-step-1-26159https://curecurrent.com/trials/adapting-multiple-behavior-interventions-that-effectively-improve-cancer-survivor-health-cancer-survivor-health-26160https://curecurrent.com/trials/phase-ii-study-of-systemic-screening-in-pathologic-node-positive-breast-cancer-26161https://curecurrent.com/trials/determining-the-biodistribution-of-an-imaging-tracer-68ga-fapi-46-in-patients-with-solid-tumors-or-hematologic-cancers-26162https://curecurrent.com/trials/trastuzumab-and-rad001-in-patients-with-human-epidermal-growth-receptor-2-her-2-overexpressing-breast-cancer-26163https://curecurrent.com/trials/serial-fes-pet-ct-to-measure-hormone-expression-in-patients-undergoing-endocrine-targeted-therapy-26164https://curecurrent.com/trials/effects-of-a-nursing-led-communication-using-mobile-health-information-in-breast-cancer-patients-undergoing-concurrent-c-26165https://curecurrent.com/trials/orasis-in-breast-reconstruction-26166https://curecurrent.com/trials/screening-colonoscopy-in-breast-cancer-patients-26167https://curecurrent.com/trials/exopert-emerald-clinical-study-26168https://curecurrent.com/trials/neoadjuvant-pembrolizumab-decitabine-followed-by-std-neoadj-chemo-for-locally-advanced-her2-breast-ca-26169https://curecurrent.com/trials/a-study-to-test-the-effect-of-the-drug-larotrectinib-in-adults-and-children-with-ntrk-fusion-positive-solid-tumors-26170https://curecurrent.com/trials/intraoperative-neuromonitoring-ionm-and-bipolar-electrocautery-be-during-axillary-lymph-node-dissection-alnd-26171https://curecurrent.com/trials/magnetic-resonance-imaging-of-breast-cancer-26172https://curecurrent.com/trials/respiratory-muscle-strength-training-to-prevent-respiratory-muscle-weakness-in-adults-newly-diagnosed-with-breast-cancer-26173https://curecurrent.com/trials/the-immune-effects-of-fermented-wheat-germ-nutritional-supplementation-in-patients-with-advanced-solid-tumor-cancers-bei-26174https://curecurrent.com/trials/tvb-2640-and-trastuzumab-with-paclitaxel-or-endocrine-therapy-for-treatment-of-her2-positive-metastatic-breast-cancer-26175https://curecurrent.com/trials/an-investigational-scan-64cu-dota-trastuzumab-pet-mri-in-imaging-patients-with-her2-breast-cancer-with-brain-metastasis-26176https://curecurrent.com/trials/monitoring-early-response-to-targeted-therapy-in-stage-iv-her2-breast-cancer-patients-with-advanced-pet-mr-imaging-26177https://curecurrent.com/trials/regional-radiotherapy-in-biomarker-low-risk-node-positive-and-t3n0-breast-cancer-26178https://curecurrent.com/trials/uhfus-characterization-of-normal-lymphatic-anatomy-26179https://curecurrent.com/trials/evaluating-the-performance-of-ai-in-evaluating-breast-mri-performed-with-dose-reduction-26180https://curecurrent.com/trials/safety-of-breast-conserving-surgery-for-multifocal-or-multicentric-breast-cancer-26181https://curecurrent.com/trials/ultra-hypofractionated-vs-moderate-hypofractionated-radiotherapy-for-regional-lymph-nodes-in-high-risk-breast-cancer-26182https://curecurrent.com/trials/effect-of-virtual-reality-guided-imagery-on-pain-anxiety-and-fatigue-in-cancer-patients-undergoing-chemotherapy-26183https://curecurrent.com/trials/a-study-to-learn-about-the-relationship-between-hepatic-impairment-and-myelosuppression-decreased-bone-marrow-function-i-26184https://curecurrent.com/trials/manual-lymphatic-drainage-with-diaphragmatic-breathing-exercises-in-post-radical-mastectomy-26185https://curecurrent.com/trials/the-effect-of-animation-video-and-training-booklet-designed-on-breast-cancer-26186https://curecurrent.com/trials/improving-comprehensive-care-of-cancer-patients-26187https://curecurrent.com/trials/clonal-hematopoiesis-chemotherapy-and-radiation-effects-study-26188https://curecurrent.com/trials/investigating-mechanisms-to-explain-age-associated-differences-in-quality-of-life-among-breast-cancer-patients-26189https://curecurrent.com/trials/multi-epitope-folate-receptor-alpha-peptide-vaccine-gm-csf-and-cyclophosphamide-in-treating-patients-with-triple-negativ-26190https://curecurrent.com/trials/prophylaxis-of-hematologic-complications-with-naderin-in-first-line-breast-cancer-chemotherapy-26191https://curecurrent.com/trials/cryo-touch-cryoablation-of-the-primary-breast-tumor-in-metastatic-breast-cancer-26192https://curecurrent.com/trials/gynaecological-care-for-transgender-people-in-france-in-2024-26193https://curecurrent.com/trials/empowerher-hybrid-digital-intervention-for-breast-cancer-survivors-26194https://curecurrent.com/trials/safety-and-preliminary-effectiveness-of-bnt327-an-investigational-therapy-for-breast-cancer-when-given-in-combination-wi-26195https://curecurrent.com/trials/pre-operative-window-of-et-to-inform-rt-decisions-power-ii-26196https://curecurrent.com/trials/european-treatment-patterns-and-outcomes-associated-with-first-line-cdk4-6-inhibition-and-hormonal-therapies-26197https://curecurrent.com/trials/a-phase-iii-active-controlled-study-of-shr-a1811-versus-trastuzumab-emtansine-t-dm1-in-her2-positive-primary-breast-canc-26198https://curecurrent.com/trials/efficacy-of-serratus-anterior-plane-block-with-dexmedetomidine-during-breast-surgery-26199https://curecurrent.com/trials/a-phase-ii-study-of-radiation-therapy-to-treat-refractory-breast-cancer-26200https://curecurrent.com/trials/the-effect-of-technological-based-rehabilitation-practices-after-breast-cancer-surgery-26201https://curecurrent.com/trials/evaluating-a-physical-activity-index-for-assessment-and-counseling-for-breast-and-colon-cancer-survivors-26202https://curecurrent.com/trials/molecular-imaging-of-her2-expression-in-her2-positive-breast-cancer-using-99mtc-adapt6-vs-99mtc-darping3-26203https://curecurrent.com/trials/evaluation-of-a-once-per-day-regimen-of-accelerated-partial-breast-irradiation-for-improved-breast-appearance-in-pts-w-l-26204https://curecurrent.com/trials/paclitaxel-with-or-without-carboplatin-and-or-bevacizumab-followed-by-doxorubicin-and-cyclophosphamide-in-treating-patie-26205https://curecurrent.com/trials/study-of-the-therabionic-p1-device-in-patients-with-metastatic-triple-negative-breast-cancer-after-progression-26206https://curecurrent.com/trials/clever-pilot-trial-a-phase-ii-pilot-trial-of-hydroxychloroquine-everolimus-or-the-combination-for-prevention-of-recurren-26207https://curecurrent.com/trials/feasibility-study-of-biobehavioral-stress-reduction-intervention-in-patients-with-triple-negative-breast-cancer-26208https://curecurrent.com/trials/a-formative-evaluation-for-improving-breast-cancer-hormone-receptor-testing-in-tanzania-26209https://curecurrent.com/trials/online-mindfulness-based-stress-reduction-for-patients-receiving-chemotherapy-26210https://curecurrent.com/trials/fes-pet-ct-in-predicting-response-in-patients-with-newly-diagnosed-metastatic-breast-cancer-receiving-endocrine-therapy-26211https://curecurrent.com/trials/effects-of-core-focused-exercise-training-and-kinesiology-taping-in-women-with-breast-cancer-related-lymphedema-26212https://curecurrent.com/trials/protective-effects-of-the-nutritional-supplement-sulforaphane-on-doxorubicin-associated-cardiac-dysfunction-26213https://curecurrent.com/trials/a-trial-comparing-gq1005-and-t-dm1-in-patients-with-her2-positive-unresectable-or-metastatic-breast-cancer-26214https://curecurrent.com/trials/a-novel-intraoperative-fluorescence-guided-system-for-evaluating-margins-during-breast-conserving-surgery-for-breast-can-26215https://curecurrent.com/trials/wide-excision-alone-as-treatment-for-ductal-carcinoma-in-situ-of-the-breast-26216https://curecurrent.com/trials/predicting-response-to-immunotherapy-from-analysis-of-live-tumor-biopsies-elephas-05-26217https://curecurrent.com/trials/integrated-cancer-repository-for-cancer-research-26218https://curecurrent.com/trials/a-study-of-emiltatug-ledadotin-emi-le-in-participants-with-solid-tumors-26219https://curecurrent.com/trials/the-precision-trial-profiling-early-breast-cancer-for-radiotherapy-omission-a-phase-ii-study-of-breast-conserving-surger-26220https://curecurrent.com/trials/neoadjuvant-radiation-in-locally-advanced-breast-cancer-26221https://curecurrent.com/trials/mri-and-mammography-before-surgery-in-patients-with-stage-i-ii-breast-cancer-26222https://curecurrent.com/trials/nurse-led-self-management-program-on-taste-alteration-in-women-with-breast-cancer-26223https://curecurrent.com/trials/phase-ii-trial-of-disulfiram-with-copper-in-metastatic-breast-cancer-26224https://curecurrent.com/trials/prediction-of-neoadjuvant-therapy-efficacy-and-prognosis-for-breast-cancer-based-on-multimodal-data-26225https://curecurrent.com/trials/molecular-imaging-of-her2-expression-in-breast-cancer-using-99mtc-zher2-26226https://curecurrent.com/trials/molecular-imaging-of-gastrin-releasing-peptide-receptors-using-labeled-technetium-99m-db8-26227https://curecurrent.com/trials/menstrual-cycle-maintenance-and-quality-of-life-a-prospective-study-26228https://curecurrent.com/trials/the-care-tracker-study-using-patient-reported-data-to-address-racial-disparity-in-cancer-treatment-26229https://curecurrent.com/trials/the-efficacy-of-combined-peripheral-blood-ctcs-and-serum-her2-detection-in-docetaxel-based-treatment-for-her2-low-expres-26230https://curecurrent.com/trials/paclitaxel-cyclophosphamide-with-or-without-trastuzumab-before-surgery-in-treating-previously-untreated-breast-cancer-26231https://curecurrent.com/trials/the-effect-of-a-post-operative-exercise-programme-versus-standard-care-on-physical-fitness-of-patients-with-breast-cance-26232https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-orally-administered-extract-of-orthosiphon-stamineus-nuvastatictm-c5osew5-26233https://curecurrent.com/trials/the-potential-cardioprotective-effect-of-addition-of-atorvastatin-in-breast-cancer-patients-26234https://curecurrent.com/trials/ribociclib-vs-palbociclib-in-patients-with-advanced-breast-cancer-within-the-her2-enriched-intrinsic-subtype-26235https://curecurrent.com/trials/implementation-of-indocyanine-green-to-identify-sentinel-lymph-nodes-during-surgery-for-breast-cancer-26236https://curecurrent.com/trials/circulating-tumor-dna-based-minimal-residual-disease-detection-for-patients-with-early-stage-breast-cancer-26237https://curecurrent.com/trials/intravenous-and-intraperitoneal-paclitaxel-and-oral-nilotinib-for-peritoneal-carcinomatosis-26238https://curecurrent.com/trials/prospective-cohort-study-of-local-recurrence-after-radical-breast-cancer-resection-26239https://curecurrent.com/trials/genetic-risk-assessment-for-cancer-education-and-empowerment-grace-project-26240https://curecurrent.com/trials/correlation-of-molecular-markers-with-response-to-therapy-and-breast-cancer-behavior-26241https://curecurrent.com/trials/preoperative-nicotine-cessation-for-women-with-breast-cancer-recommended-for-reconstruction-26242https://curecurrent.com/trials/stereotactic-body-radiation-therapy-in-treating-patients-with-metastatic-breast-cancer-non-small-cell-lung-cancer-or-pro-26243https://curecurrent.com/trials/tolerability-of-the-combination-of-lapatinib-and-trastuzumab-in-adults-age-60-or-older-with-her2-positive-locally-advanc-26244https://curecurrent.com/trials/an-open-label-randomized-phase-iii-study-of-trastuzumab-rezetecan-with-or-without-bevacizumab-in-first-to-third-line-bli-26245https://curecurrent.com/trials/molecular-imaging-of-fibroblast-activation-protein-expression-using-labeled-technetium-99m-hynic-fapi-26246https://curecurrent.com/trials/first-time-in-human-study-of-gsk4381562-in-participants-with-advanced-solid-tumors-26247https://curecurrent.com/trials/emdr-psychotherapy-to-treat-anxious-depressive-symptoms-in-breast-cancer-patient-26248https://curecurrent.com/trials/elacestrant-in-patients-with-er-her2-esr1-mutated-locally-advanced-or-metastatic-breast-cancer-26249https://curecurrent.com/trials/cancer-exercise-evaluation-of-a-mobile-app-in-breast-cancer-survivors-26250https://curecurrent.com/trials/asteroid-a-trial-of-astx660-in-combination-with-pembrolizumab-26251https://curecurrent.com/trials/99mtc-adapt6-spect-based-non-invasive-quantification-of-her2-expression-in-breast-cancer-with-metastatic-lymph-nodes-26252https://curecurrent.com/trials/riss-versus-spsip-block-in-modified-radical-mastectomy-26253https://curecurrent.com/trials/a-pre-post-pilot-of-a-smartphone-intervention-26254https://curecurrent.com/trials/molecular-imaging-of-gastrin-releasing-peptide-receptors-using-labeled-technetium-99m-rm26-26255https://curecurrent.com/trials/investigating-the-feasibility-and-acceptability-of-an-innovative-interdisciplinary-supportive-care-program-couples-copin-26256https://curecurrent.com/trials/effectiveness-and-impact-of-the-lived-experience-cancer-awareness-campaign-on-screening-participation-26257https://curecurrent.com/trials/99mtc-darping3-based-her2-expression-molecular-imaging-in-her2-positive-breast-cancer-during-chemo-targeted-therapy-26258https://curecurrent.com/trials/99mtc-adapt6-based-her2-imaging-in-breast-cancer-26259https://curecurrent.com/trials/a-phase-ii-clinical-study-of-the-efficacy-and-safety-of-culmerciclib-rechallenge-in-hr-positive-her2-negative-breast-can-26260https://curecurrent.com/trials/99mtc-tc-db8-accumulation-in-primary-tumor-in-breast-cancer-with-positive-and-negative-estrogen-receptor-expression-26261https://curecurrent.com/trials/feasibility-study-of-adjuvant-enzalutamide-for-the-treatment-of-early-stage-ar-triple-negative-breast-cancer-26262https://curecurrent.com/trials/molecular-imaging-of-her2-expression-in-breast-cancer-using-99mtc-tc-g3-g3s-3c-before-chemo-targeted-therapy-26263https://curecurrent.com/trials/molecular-imaging-of-her2-expression-in-breast-cancer-using-99mtc-he3-g3-26264https://curecurrent.com/trials/99mtc-darping3-spect-ct-for-non-invasive-her2-ax-in-breast-cancer-with-metastatic-lymph-nodes-before-targeted-therapy-26265https://curecurrent.com/trials/evaluation-of-different-types-of-her2-expression-in-breast-cancer-using-99mtc-tc-zher2-4107-26266https://curecurrent.com/trials/a-mixed-methods-metabolomics-investigation-of-lifestyle-and-energy-balance-during-breast-cancer-survivorship-26267https://curecurrent.com/trials/neoadjuvant-complete-response-customized-treatment-approach-for-definitive-management-of-breast-cancer-26268https://curecurrent.com/trials/oncology-treatment-related-ocular-surface-changes-26269https://curecurrent.com/trials/molecular-imaging-of-her2-expression-in-breast-cancer-using-123i-i-he-3-g3-26270https://curecurrent.com/trials/circulating-tumor-dna-to-guide-changes-in-standard-of-care-chemotherapy-26271https://curecurrent.com/trials/a-long-term-treatment-extension-study-of-niraparib-in-participants-who-completed-a-prior-glaxosmithkline-tesaro-sponsore-26272https://curecurrent.com/trials/phenotypic-spectrum-of-ctcs-in-tumors-of-the-female-reproductive-system-26273https://curecurrent.com/trials/mainstreaming-genetics-evaluation-of-a-digital-application-to-scale-and-spread-oncologist-initiated-genetic-testing-26274https://curecurrent.com/trials/phase-1-2-study-of-etx-636-in-participants-with-advanced-solid-tumors-26275https://curecurrent.com/trials/resistance-vs-aerobic-training-on-breast-cancer-patients-undergoing-neoadjuvant-treatment-26276https://curecurrent.com/trials/secondary-brain-metastases-prevention-after-isolated-intracranial-progression-on-trastuzumab-pertuzumab-or-t-dm1-in-pati-26277https://curecurrent.com/trials/breast-cancer-screening-decision-aid-26278https://curecurrent.com/trials/study-to-assess-adverse-events-and-pharmacokinetics-in-adult-participants-with-non-small-cell-lung-cancer-head-and-neck-26279https://curecurrent.com/trials/paclitaxel-nab-paclitaxel-or-ixabepilone-with-or-without-bevacizumab-in-treating-patients-with-stage-iiic-or-stage-iv-br-26280https://curecurrent.com/trials/observational-study-on-the-treatment-of-patients-with-metastatic-breast-cancer-26281https://curecurrent.com/trials/a-study-of-investigational-drug-cfi-402257-in-patients-with-advanced-solid-tumors-26282https://curecurrent.com/trials/palbociclib-and-endocrine-therapy-for-lobular-breast-cancer-preoperative-study-pelops-26283https://curecurrent.com/trials/addtional-effect-of-hyperbaric-oxygen-to-programmed-physical-activity-on-musckoloskeletal-pain-in-breast-cancer-elderly-26284https://curecurrent.com/trials/circulating-tumor-dna-dynamics-to-optimize-neoadjuvant-therapy-in-her2-positive-and-triple-negative-breast-cancer-26285https://curecurrent.com/trials/bevacizumab-in-treating-patients-with-metastatic-breast-cancer-that-overexpresses-her-2-neu-26286https://curecurrent.com/trials/a-study-of-ly4175408-in-participants-with-advanced-cancer-26287https://curecurrent.com/trials/mrg-nirs-imaging-system-breast-cancer-trial-26288https://curecurrent.com/trials/leuprolide-and-goserelin-for-ovarian-function-suppression-in-pre-or-peri-menopausal-women-with-breast-cancer-ofs-trial-26289https://curecurrent.com/trials/pain-monitoring-after-breast-biopsy-benefit-of-e-health-26290https://curecurrent.com/trials/breast-and-cervical-cancer-stigma-in-rwanda-26291https://curecurrent.com/trials/18f-fpyqcp-pet-imaging-of-fibroblast-activation-protein-in-selected-oncology-indications-26292https://curecurrent.com/trials/culturally-adapting-an-intervention-to-increase-genetic-testing-in-african-american-cancer-survivors-26293https://curecurrent.com/trials/bre-04-window-of-opportunity-trial-of-preoperative-low-dose-azacitidine-in-high-risk-early-stage-breast-cancer-26294https://curecurrent.com/trials/oral-zn-telomir-monotherapy-in-patients-with-advanced-or-metastatic-triple-negative-breast-cancer-tnbc-26295https://curecurrent.com/trials/adaptation-of-a-values-assessment-tool-26296https://curecurrent.com/trials/observational-study-of-intra-operative-partial-irradiation-of-invasive-ductal-breast-carcinomas-with-a-good-prognosis-26297https://curecurrent.com/trials/circulating-tumour-cells-characterization-in-breast-cancer-patients-26298https://curecurrent.com/trials/comparison-between-roll-versus-magnetic-seed-for-preoperative-localization-of-non-palpable-breast-lesion-by-randomized-c-26299https://curecurrent.com/trials/roll-versus-magnetic-seed-for-preoperative-localization-of-non-palpable-breast-lesion-comparison-between-techniques-26300https://curecurrent.com/trials/a-randomized-two-arm-proof-of-concept-study-testing-a-novel-approach-to-exercise-promotion-based-on-affect-regulation-26301https://curecurrent.com/trials/a-phase-1-first-in-human-study-of-the-anti-cd73-iph5301-alone-or-in-combination-with-chemotherapy-and-trastuzumab-in-pat-26302https://curecurrent.com/trials/evaluation-of-lasofoxifene-combined-with-abemaciclib-compared-with-fulvestrant-combined-with-abemaciclib-in-locally-adva-26303https://curecurrent.com/trials/impact-of-prehabilitation-and-comprehensive-follow-up-in-women-with-breast-cancer-26304https://curecurrent.com/trials/hypofractionated-vs-conventional-rt-after-prosthetic-breast-reconstruction-26305https://curecurrent.com/trials/study-of-xb010-in-subjects-with-solid-tumors-26306https://curecurrent.com/trials/study-of-erw316-as-a-single-agent-or-in-combination-with-endocrine-therapy-in-patients-with-hr-her2-breast-cancer-and-ot-26307https://curecurrent.com/trials/impact-of-video-information-support-on-preoperative-anxiety-in-breast-cancer-surgery-26308https://curecurrent.com/trials/a-study-evaluating-bemarituzumab-in-solid-tumors-with-fibroblast-growth-factor-receptor-2b-fgfr2b-overexpression-26309https://curecurrent.com/trials/a-study-of-ly3484356-in-participants-with-advanced-or-metastatic-breast-cancer-or-endometrial-cancer-26310https://curecurrent.com/trials/phase-1-2-study-to-evaluate-ep0062-as-monotherapy-and-in-combination-in-patients-with-advanced-or-metastatic-ar-her-2-er-26311https://curecurrent.com/trials/assessment-of-cryotherapy-s-analgesic-impact-in-anti-aromatase-induced-arthralgia-26312https://curecurrent.com/trials/effects-of-myofascial-massage-and-patient-therapist-communication-levels-on-shoulder-muscle-properties-in-breast-cancer-26313https://curecurrent.com/trials/remotely-delivered-community-aligned-weight-loss-interventions-among-breast-cancer-survivors-vida-trial-26314https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-using-platelet-rich-fibrin-prf-based-lipobolus-for-the-immediate-reconstruction-26315https://curecurrent.com/trials/new-approaches-for-the-identification-and-characterization-of-functional-markers-of-the-risk-of-extension-of-breast-canc-26316https://curecurrent.com/trials/rad001-plus-docetaxel-in-patients-with-metastatic-breast-cancer-26317https://curecurrent.com/trials/scalp-cooling-in-mbc-26318https://curecurrent.com/trials/optimal-application-timing-of-adc-drugs-for-advanced-breast-cancer-26319https://curecurrent.com/trials/a-study-of-ide034-in-adult-participants-with-locally-advanced-metastatic-solid-tumors-types-26320https://curecurrent.com/trials/group-positive-psychology-based-program-for-fear-of-breast-cancer-recurrence-26321https://curecurrent.com/trials/losartan-to-reduce-radiation-induced-fibrosis-in-breast-cancer-patients-26322https://curecurrent.com/trials/risk-stratified-hypofractionated-radiotherapy-after-breast-conserving-surgery-for-early-breast-cancer-26323https://curecurrent.com/trials/single-fraction-interstitial-breast-brachytherapy-26324https://curecurrent.com/trials/investigating-the-use-of-tavns-to-treat-insomnia-in-individuals-with-breast-cancer-tavns-insomnia-bc-26325https://curecurrent.com/trials/in-situ-immunomodulation-with-cdx-301-radiation-therapy-cdx-1140-and-poly-iclc-in-patients-w-unresectable-and-metastatic-26326https://curecurrent.com/trials/a-clinical-trial-comparing-the-efficacy-and-safety-of-different-doses-of-bl0175-injection-in-treating-postmenopausal-hor-26327https://curecurrent.com/trials/molecular-subtype-guided-postoperative-radiotherapy-for-phyllodes-tumor-of-the-breast-a-randomized-controlled-trial-26328https://curecurrent.com/trials/a-study-of-xmt-2056-in-advanced-recurrent-solid-tumors-that-express-her2-26329https://curecurrent.com/trials/interest-of-virtual-reality-on-anxiety-before-the-planning-ct-scan-in-radiotherapy-26330https://curecurrent.com/trials/a-study-to-examine-the-safety-of-different-doses-of-bg-68501-given-to-participants-with-advanced-stage-tumors-26331https://curecurrent.com/trials/circulating-tumor-dna-and-immunophenotyping-as-potential-biomarkers-with-regional-nodal-irradiation-for-breast-cancer-26332https://curecurrent.com/trials/radiation-immunotherapy-and-parp-inhibitor-in-triple-negative-breast-cancer-26333https://curecurrent.com/trials/hypofractionated-locoregional-radiotherapy-in-breast-cancer-26334https://curecurrent.com/trials/a-post-marketing-surveillance-on-piqray-in-korea-26335https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-adjuvant-giredestrant-compared-with-physician-s-choice-of-adjuvant-endocri-26336https://curecurrent.com/trials/swiss-multi-centre-randomized-placebo-controlled-trial-of-pregabalin-for-prevention-of-persistent-pain-in-high-risk-pati-26337https://curecurrent.com/trials/probiotics-for-prevention-of-neratinib-induced-diarrhea-in-breast-cancer-patients-26338https://curecurrent.com/trials/emotional-distress-in-patients-with-metastatic-breast-cancer-in-first-line-of-therapy-26339https://curecurrent.com/trials/patterns-of-care-and-outcomes-in-locally-recurrent-inoperable-or-metastatic-triple-negative-breast-cancer-26340https://curecurrent.com/trials/single-cell-immune-and-non-immune-correlates-of-response-to-neoadjuvant-abemaciclib-26341https://curecurrent.com/trials/sequential-ehr-based-interventions-to-increase-genetic-testing-for-breast-and-ovarian-cancer-predisposition-26342https://curecurrent.com/trials/a-prospective-cohort-study-evaluating-risk-of-local-recurrence-following-breast-conserving-surgery-and-endocrine-therapy-26343https://curecurrent.com/trials/a-phase-ii-observational-clinical-study-on-the-relationship-between-cerebrospinal-fluid-drug-concentration-and-efficacy-26344https://curecurrent.com/trials/cd40-agonist-flt3-ligand-and-chemotherapy-in-her2-negative-breast-cancer-26345https://curecurrent.com/trials/familial-investigations-of-childhood-cancer-predisposition-26346https://curecurrent.com/trials/pg2-breast-cancer-evaluation-in-adjuvant-medicine-study-26347https://curecurrent.com/trials/cachexia-and-gut-microbiota-in-patients-with-breast-cancer-receiving-home-care-26348https://curecurrent.com/trials/pvx-410-vaccine-plus-pembrolizumab-in-hla-a2-metastatic-triple-negative-breast-cancer-26349https://curecurrent.com/trials/nivolumab-and-ipilimumab-in-treating-patients-with-rare-tumors-26350https://curecurrent.com/trials/phase-i-study-of-177lu-lu-dfc413-in-patients-with-solid-tumors-26351https://curecurrent.com/trials/a-phase-i-study-of-niraparib-administered-concurrently-with-postoperative-rt-in-triple-negative-breast-cancer-patients-26352https://curecurrent.com/trials/efficacy-and-safety-of-non-invasive-vagal-stimulation-to-prevent-chemotherapy-induced-nausea-26353https://curecurrent.com/trials/pembrolizumab-and-carboplatin-in-treating-patients-with-circulating-tumor-cells-positive-metastatic-breast-cancer-26354https://curecurrent.com/trials/a-study-of-the-body-s-response-to-exercise-and-a-plant-based-diet-in-overweight-postmenopausal-women-with-breast-cancer-26355https://curecurrent.com/trials/a-study-evaluating-the-efficacy-and-safety-of-giredestrant-plus-everolimus-compared-with-the-physician-s-choice-of-endoc-26356https://curecurrent.com/trials/safety-feasibility-and-outcomes-of-early-rehabilitation-after-breast-cancer-surgery-26357https://curecurrent.com/trials/a-study-to-investigate-the-safety-pharmacokinetics-and-preliminary-efficacy-of-ide574-therapy-in-adult-participants-with-26358https://curecurrent.com/trials/a-clinical-study-of-sys6023-combination-therapy-for-advanced-breast-cancer-26359https://curecurrent.com/trials/immune-response-to-anti-her2-therapies-in-patients-with-her2-positive-stage-i-iv-breast-cancer-26360https://curecurrent.com/trials/upfront-targeted-axillary-dissection-for-luminal-breast-cancer-with-limited-axillary-involvement-26361https://curecurrent.com/trials/a-physical-activity-program-compared-to-health-education-for-improving-memory-and-attention-in-hispanic-women-with-newly-26362https://curecurrent.com/trials/reishi-mushroom-extract-for-fatigue-and-or-arthralgias-myalgias-in-patients-with-breast-cancer-on-aromatase-inhibitors-26363https://curecurrent.com/trials/bilevel-erector-spinae-plane-block-versus-pectoserratus-block-for-analgesia-in-modified-radical-mastectomy-26364https://curecurrent.com/trials/pertuzumab-trastuzumab-and-paclitaxel-albumin-stabilized-nanoparticle-formulation-in-treating-patients-with-her2-positiv-26365https://curecurrent.com/trials/an-ophthalmic-safety-study-in-patients-with-breast-cancer-26366https://curecurrent.com/trials/the-clinical-application-value-of-spect-imaging-targeting-lrrc15-in-malignant-tumors-26367https://curecurrent.com/trials/neoadjuvant-weekly-paclitaxel-and-biomarkers-of-therapy-response-26368https://curecurrent.com/trials/evaluating-6-months-of-her2-targeted-therapy-in-patients-with-her2-positive-early-stage-breast-cancer-that-achieve-a-pat-26369https://curecurrent.com/trials/trial-to-evaluate-the-impact-of-various-pragmatic-interventions-to-increase-mammography-uptake-among-defaulted-repeat-sc-26370https://curecurrent.com/trials/artificial-intelligence-powered-digital-education-based-on-the-neuman-systems-model-for-breast-cancer-patients-receiving-26371https://curecurrent.com/trials/focused-ultrasound-and-gemcitabine-in-breast-cancer-26372https://curecurrent.com/trials/comparison-immune-response-in-paravertebral-and-erector-spinal-plane-block-in-breast-cancer-patients-26373https://curecurrent.com/trials/opportunistic-breast-cancer-screening-using-non-contrast-chest-ct-26374https://curecurrent.com/trials/judicious-surveillance-for-trastuzumab-induced-cardiotoxicity-in-the-first-year-26375https://curecurrent.com/trials/3d-ultrasound-for-the-imaging-of-lymph-nodes-in-patients-with-breast-cancer-26376https://curecurrent.com/trials/a-real-world-study-of-early-breast-cancer-patients-eligible-for-treatment-with-cdk4-6-inhibitors-26377https://curecurrent.com/trials/bioequivalence-study-of-liposomal-doxorubicin-20-mg-10-ml-doxopeg-vs-caelyx-in-advanced-cancer-patients-26378https://curecurrent.com/trials/treating-breast-cancer-patients-undergoing-trastuzumab-treatment-with-carvedilol-to-reduce-incidence-of-heart-failure-26379https://curecurrent.com/trials/meliora-virtual-coach-intervention-for-breast-cancer-prevention-26380https://curecurrent.com/trials/pilot-study-of-an-ntprobnp-guided-strategy-of-cardioprotection-26381https://curecurrent.com/trials/trastuzumab-deruxtecan-plus-ivonescimab-for-hormone-receptor-positive-her2-negative-advanced-breast-cancer-study-26382https://curecurrent.com/trials/a-clinical-study-on-prophylactic-response-to-hetrombopag-for-secondary-prevention-in-anti-cancer-therapy-induced-thrombo-26383https://curecurrent.com/trials/espb-versus-perioperative-iv-lidocaine-infusion-on-proinflammatory-cytokines-in-breast-cancer-surgeries-26384https://curecurrent.com/trials/trastuzumab-rezetecan-neoadjuvant-therapy-in-thp-insensitive-her2-positive-early-breast-cancer-26385https://curecurrent.com/trials/part-ii-exercise-in-hispanic-breast-cancer-survivors-26386https://curecurrent.com/trials/hypofractionated-regional-nodal-irradiation-clinical-trial-for-women-with-breast-cancer-26387https://curecurrent.com/trials/bal0891-in-patients-with-advanced-solid-tumors-or-relapsed-or-refractory-acute-myeloid-leukemia-26388https://curecurrent.com/trials/palbociclib-collaborative-adjuvant-study-26389https://curecurrent.com/trials/t-dm1-and-tucatinib-compared-with-t-dm1-alone-in-preventing-relapses-in-people-with-high-risk-her2-positive-breast-cance-26390https://curecurrent.com/trials/leflunomide-in-patients-with-pten-altered-advanced-solid-malignancies-and-her2-negative-breast-cancer-26391https://curecurrent.com/trials/two-versus-one-week-breast-radiotherapy-rt-26392https://curecurrent.com/trials/a-study-of-dato-dxd-with-or-without-durvalumab-versus-investigator-s-choice-of-therapy-in-patients-with-stage-i-iii-trip-26393https://curecurrent.com/trials/oral-aromatase-inhibitors-modify-the-gut-microbiome-26394https://curecurrent.com/trials/mobile-health-delivery-of-lifestyle-interventions-for-women-with-breast-cancer-26395https://curecurrent.com/trials/mammoverse-breast-cancer-sexual-health-focus-groups-26396https://curecurrent.com/trials/aggressive-local-therapy-for-limited-bone-only-metastasis-to-improve-progression-free-survival-in-breast-cancer-patients-26397https://curecurrent.com/trials/a-clinical-study-of-hrs-6209-combined-with-other-treatment-regimens-in-patients-with-breast-cancer-26398https://curecurrent.com/trials/mammoverse-clinicians-focus-group-26399https://curecurrent.com/trials/everst-everolimus-after-alpelisib-in-women-with-hormone-receptor-positive-hr-metastatic-breast-cancer-mbc-26400https://curecurrent.com/trials/talazoparib-in-treating-patients-with-recurrent-refractory-advanced-or-metastatic-cancers-and-alterations-in-the-brca-ge-26401https://curecurrent.com/trials/data-collection-for-the-assessment-of-acute-and-late-normal-tissue-in-patients-treated-with-proton-therapy-26402https://curecurrent.com/trials/engaging-m-health-for-symptom-monitoring-and-health-promotion-for-women-on-endocrine-therapy-for-breast-cancer-emshape-26403https://curecurrent.com/trials/a-radiotracer-18f-fluorthanatrace-by-pet-ct-for-the-imaging-of-breast-cancer-26404https://curecurrent.com/trials/involvement-of-the-inositol-trisphosphate-receptor-in-invasive-or-migratory-type-breast-cancers-26405https://curecurrent.com/trials/18f-fes-pet-mri-for-tailoring-treatment-of-luminal-a-and-lobular-breast-cancer-26406https://curecurrent.com/trials/the-0504-in-patients-with-solid-tumors-26407https://curecurrent.com/trials/tridimensional-geometric-modeling-of-the-breast-26408https://curecurrent.com/trials/percutaneous-biopsy-after-neoadjuvant-chemotherapy-26409https://curecurrent.com/trials/trastuzumab-deruxtecan-t-dxd-in-patients-who-have-hormone-receptor-negative-and-hormone-receptor-positive-her2-low-or-he-26410https://curecurrent.com/trials/open-label-umbrella-study-to-evaluate-safety-and-efficacy-of-elacestrant-in-various-combination-in-participants-with-met-26411https://curecurrent.com/trials/her2-fpbmc-in-patients-with-metastatic-breast-and-prostate-cancer-am006-26412https://curecurrent.com/trials/metformin-for-the-treatment-of-insulin-resistance-in-women-with-stage-i-iii-breast-cancer-completing-chemotherapy-26413https://curecurrent.com/trials/impact-of-dietary-inflammatory-potential-on-breast-cancer-risk-26414https://curecurrent.com/trials/roll-over-study-for-patients-who-have-completed-a-previous-oncology-study-with-olaparib-26415https://curecurrent.com/trials/breast-conserving-surgery-and-radiation-therapy-in-patients-with-multiple-ipsilateral-breast-cancer-26416https://curecurrent.com/trials/talking-to-employers-and-medical-staff-about-breast-cancer-treatment-and-your-job-26417https://curecurrent.com/trials/evaluating-an-ai-based-mobile-application-for-chemotherapy-support-in-breast-cancer-patients-26418https://curecurrent.com/trials/prehabilitation-with-resistance-exercise-training-for-breast-cancer-neoadjuvant-therapy-26419https://curecurrent.com/trials/magnetic-resonance-imaging-in-radiotherapy-for-breast-cancer-26420https://curecurrent.com/trials/early-point-of-service-social-and-behavioral-determinants-of-health-sbdoh-screening-and-enhanced-navigation-on-care-deli-26421https://curecurrent.com/trials/pembrolizumab-in-treating-patients-with-hormone-receptor-positive-localized-inflammatory-breast-cancer-who-are-receiving-26422https://curecurrent.com/trials/a-phase-1-1b-of-rndo-564-single-agent-or-in-combination-with-pembrolizumab-in-bladder-cancer-and-other-solid-tumors-asso-26423https://curecurrent.com/trials/behavior-change-wheel-based-music-listening-for-chemotherapy-related-cognitive-impairment-in-breast-cancer-patients-26424https://curecurrent.com/trials/evaluation-of-the-medical-service-by-socio-aesthetics-in-oncology-26425https://curecurrent.com/trials/mem-288-oncolytic-virus-alone-and-in-combination-with-standard-of-care-therapy-in-advanced-solid-tumors-26426https://curecurrent.com/trials/de-escalation-of-axillary-management-in-advanced-nodal-disease-26427https://curecurrent.com/trials/efti-in-patients-with-hormone-receptor-positive-her2-neg-breast-cancer-26428https://curecurrent.com/trials/a-novel-fluorescent-ductal-needle-for-localization-and-sampling-of-micro-lesions-in-breast-ducts-26429https://curecurrent.com/trials/safety-and-tolerability-of-pb-dotam-grpr1-in-adult-subjects-with-recurrent-or-metastatic-grpr-expressing-tumors-26430https://curecurrent.com/trials/prognostic-impact-of-the-neutrophil-lymphocyte-ratio-nlr-in-the-treatment-of-first-line-metastatic-or-locally-advanced-b-26431https://curecurrent.com/trials/cancer-survivors-program-26432https://curecurrent.com/trials/exploratory-study-of-shr-a1811-via-different-administration-routes-in-patients-26433https://curecurrent.com/trials/cancer-lipidome-adaptation-and-resculping-through-omega-3-pufas-in-breast-tumors-26434https://curecurrent.com/trials/avapritinib-for-the-treatment-of-ckit-or-pdgfra-mutation-positive-locally-advanced-or-metastatic-malignant-solid-tumors-26435https://curecurrent.com/trials/neoadjuvant-dalpiciclib-ai-shr-a1811-for-hr-her2-low-breast-cancer-26436https://curecurrent.com/trials/the-role-of-lifestyle-factors-in-breast-cancer-related-outcomes-26437https://curecurrent.com/trials/effect-of-yoga-program-on-quality-of-life-in-women-with-breast-cancer-receiving-endocrine-therapy-26438https://curecurrent.com/trials/a-novel-fluorescent-ductal-needle-for-localization-and-sampling-of-high-risk-breast-micro-lesions-26439https://curecurrent.com/trials/18f-fes-pet-ct-in-endocrine-refractory-breast-cancer-26440https://curecurrent.com/trials/real-time-mri-guided-3-fraction-accelerated-partial-breast-irradiation-in-early-breast-cancer-26441https://curecurrent.com/trials/arx788-for-treating-patients-with-her2-low-locally-advanced-unresectable-or-metastatic-breast-cancer-26442https://curecurrent.com/trials/bgb-43395-alone-or-as-part-of-combination-therapies-in-chinese-participants-with-hr-her2-breast-cancer-and-other-advance-26443https://curecurrent.com/trials/evaluation-of-ga-lu-ht547-safety-biodistribution-and-dosimetry-in-solid-tumors-26444https://curecurrent.com/trials/eradicate-a-phase-ib-ii-study-of-elacestrant-plus-trastuzumab-deruxtecan-in-patients-with-cdk4-6-inhibitor-and-endocrine-26445https://curecurrent.com/trials/a-prospective-multicenter-observational-cohort-study-to-evaluate-the-efficacy-and-safety-of-a-novel-anti-tumor-drug-as-a-26446https://curecurrent.com/trials/the-efficacy-of-compression-ice-gloves-socks-in-patients-with-utd1-induced-neuropathy-26447https://curecurrent.com/trials/male-breast-cancer-predisposition-factor-26448https://curecurrent.com/trials/effect-of-an-educational-intervention-in-women-with-breast-cancer-edu-int-bc-26449https://curecurrent.com/trials/anlotinib-combined-with-chemotherapy-and-neoadjuvant-therapy-for-hormone-receptor-positive-her-2-negative-breast-cancer-26450https://curecurrent.com/trials/evaluate-the-efficacy-and-safety-of-adebrelimab-combined-with-chemotherapy-with-or-without-radiotherapy-as-neoadjuvant-t-26451https://curecurrent.com/trials/dose-determining-study-of-exs74539-rec-4539-in-participants-with-select-solid-tumors-26452https://curecurrent.com/trials/gene-expression-profiling-to-help-define-the-need-for-neo-adjuvant-chemotherapy-in-hr-her-breast-cancer-patients-26453https://curecurrent.com/trials/treatment-patterns-clinical-outcomes-of-palbociclib-combinations-in-hr-her2-mbc-26454https://curecurrent.com/trials/aspects-of-adjuvant-cdk4-6-inhibitors-in-older-breast-cancer-patients-focusing-on-geriatric-screening-26455https://curecurrent.com/trials/chatgpt-surgeon-synergy-redefining-breast-reconstruction-consultations-for-enhanced-patient-engagement-and-satisfaction-26456https://curecurrent.com/trials/phase-ii-clinical-trial-of-pd-l1-in-combination-with-vinorelbine-cyclophosphamide-capecitabine-vex-metronomic-chemothera-26457https://curecurrent.com/trials/atezolizumab-cobimetinib-and-eribulin-in-treating-patients-with-chemotherapy-resistant-metastatic-inflammatory-breast-ca-26458https://curecurrent.com/trials/prevention-of-alopecia-in-patients-with-localised-breast-cancer-26459https://curecurrent.com/trials/marathon-of-hope-cancer-centres-network-study-for-ontario-mohccn-o-26460https://curecurrent.com/trials/first-in-human-diagnostic-imaging-profile-of-the-theranostic-pair-68ga-ga-dota-str-17126-and-low-dose-177lu-lu-dota-str-26461https://curecurrent.com/trials/a-pilot-dose-escalation-trial-of-a-densified-chemotherapy-association-of-docetaxel-and-epirubicin-driven-by-mathematical-26462https://curecurrent.com/trials/evaluating-the-efficacy-and-safety-of-pd-l1-monoclonal-antibody-combined-with-vex-metronomic-chemotherapy-and-concurrent-26463https://curecurrent.com/trials/non-contrast-breast-mri-diagnosis-and-risk-stratification-using-dwi-generated-synthetic-contrast-enhancement-26464https://curecurrent.com/trials/optimizing-treatment-of-stage-iv-breast-cancer-through-real-time-disease-monitoring-26465https://curecurrent.com/trials/pyrotinib-plus-trastuzumab-and-chemotherapy-for-her2-positive-early-breast-cancer-26466https://curecurrent.com/trials/cancer-pain-management-using-a-web-based-intervention-26467https://curecurrent.com/trials/neoadjuvant-therapy-with-trastuzumab-deruxtecan-versus-chemotherapy-trastuzumab-pertuzumab-in-her2-early-breast-cancer-26468https://curecurrent.com/trials/conventional-prophylactic-oral-dexamethasone-vs-short-course-iv-dexamethasone-in-paclitaxel-hypersensitivity-26469https://curecurrent.com/trials/a-prospective-multicenter-observational-cohort-study-assessing-the-efficacy-and-safety-of-radiotherapy-sensitized-immuno-26470https://curecurrent.com/trials/increasing-germline-genetic-testing-for-patients-with-cancer-26471https://curecurrent.com/trials/a-trial-to-find-out-if-vidutolimod-together-with-cemiplimab-is-safe-and-if-it-works-in-adult-participants-with-advanced-26472https://curecurrent.com/trials/breast-phyllodes-tumors-based-on-20-year-real-world-data-from-china-26473https://curecurrent.com/trials/a-conversational-agent-cecebot-to-improve-insomnia-in-stage-i-iii-breast-cancer-survivors-26474https://curecurrent.com/trials/disease-extent-in-stage-iv-lobular-carcinoma-the-aid-of-imaging-and-liquid-biopsy-analyses-26475https://curecurrent.com/trials/physical-evaluation-and-quality-of-life-in-the-practice-of-fencing-in-breast-cancer-support-26476https://curecurrent.com/trials/genetic-analysis-in-blood-and-tumor-samples-from-patients-with-advanced-or-metastatic-estrogen-receptor-positive-and-her-26477https://curecurrent.com/trials/neoadjuvant-chemotherapy-with-wh002-in-women-with-her2-negative-breast-cancer-26478https://curecurrent.com/trials/evaluating-the-efficacy-of-pecs-ii-blockade-compared-to-local-anesthetic-infiltration-in-controlling-postoperative-pain-26479https://curecurrent.com/trials/a-phase-ii-study-of-gv20-0251-in-combination-with-anti-pd-1-monoclonal-antibodies-in-patients-with-unresectable-locally-26480https://curecurrent.com/trials/personalized-molecular-profiling-in-cancer-treatment-at-johns-hopkins-26481https://curecurrent.com/trials/a-study-to-assess-the-mass-balance-of-14c-hrs-8080-in-healthy-chinese-postmenopausal-female-subjects-26482https://curecurrent.com/trials/study-of-cx-5461-in-patients-with-solid-tumours-and-brca1-2-palb2-or-homologous-recombination-deficiency-hrd-mutation-26483https://curecurrent.com/trials/translation-of-acoustic-angiography-contrast-enhanced-super-resolution-cesr-imaging-26484https://curecurrent.com/trials/messaging-intervention-to-increase-medicare-annual-wellness-visits-the-nudge-awv-clinical-trial-26485https://curecurrent.com/trials/impact-of-radiotherapy-on-survival-in-breast-cancer-patients-26486https://curecurrent.com/trials/identification-of-sentinel-lymph-nodes-with-methylene-blue-and-isotope-26487https://curecurrent.com/trials/psychosocial-outcomes-and-contralateral-prophylactic-mastectomy-cpm-26488https://curecurrent.com/trials/a-study-of-autogene-cevumeran-ro7198457-as-a-single-agent-and-in-combination-with-atezolizumab-in-participants-with-loca-26489https://curecurrent.com/trials/music-therapy-as-a-tool-for-anxiety-reduction-in-localized-breast-cancer-26490https://curecurrent.com/trials/xenogeneic-her2-neu-dna-immunization-for-patients-with-metastatic-and-high-risk-breast-cancer-a-phase-i-study-to-assess-26491https://curecurrent.com/trials/study-of-program-interest-bouge-to-improve-the-daily-physical-activity-in-processings-treatment-of-non-metastatic-breast-26492https://curecurrent.com/trials/177lu-dotatate-for-the-treatment-of-stage-iv-or-recurrent-breast-cancer-26493https://curecurrent.com/trials/optimization-of-cardiac-imaging-in-women-with-early-stage-breast-cancer-26494https://curecurrent.com/trials/ono-4578-06-phase-i-study-of-ono-4578-and-letrozole-plus-cdk4-6-inhibitors-in-breast-cancer-26495https://curecurrent.com/trials/breast-cancer-registry-platform-26496https://curecurrent.com/trials/efficacy-and-safety-of-trastuzumab-rezetecan-or-trastuzumab-deruxtecan-in-advanced-breast-cancer-26497https://curecurrent.com/trials/manual-lymphatic-drainage-breast-massage-in-breast-cancer-patients-after-breast-conserving-surgery-26498https://curecurrent.com/trials/fulvestrant-and-or-anastrozole-in-treating-postmenopausal-patients-with-stage-ii-iii-breast-cancer-undergoing-surgery-26499https://curecurrent.com/trials/adherence-and-safety-of-ribociclib-plus-aromatase-inhibitors-in-patients-with-early-stage-hr-and-her2-breast-cancer-26500https://curecurrent.com/trials/biomarkers-of-efficacy-and-tolerability-of-sacituzumab-govitecan-in-the-treatment-of-patients-with-triple-negative-breas-26501https://curecurrent.com/trials/sac-tmt-sequential-capecitabine-versus-capecitabine-in-early-stage-high-risk-triple-negative-breast-cancer-without-brca-26502https://curecurrent.com/trials/investigation-of-the-prognostic-value-of-patterns-of-genomic-alterations-or-protein-expression-in-patients-with-operated-26503https://curecurrent.com/trials/controlled-low-calorie-diet-in-reducing-side-effects-and-increasing-response-to-chemotherapy-in-patients-with-breast-or-26504https://curecurrent.com/trials/high-dose-chemotherapy-and-autologous-transplant-for-breast-cancer-26505https://curecurrent.com/trials/taletrectinib-in-previously-treated-metastatic-cdh1-mutated-invasive-lobular-cancer-ilc-26506https://curecurrent.com/trials/follow-up-study-of-subjects-previously-enrolled-in-poxviral-vector-gene-transfer-studies-26507https://curecurrent.com/trials/palbociclib-with-fulvestrant-for-metastatic-breast-cancer-after-treatment-with-palbociclib-and-an-aromatase-inhibitor-26508https://curecurrent.com/trials/ontario-wide-cancer-targeted-nucleic-acid-evaluation-26509https://curecurrent.com/trials/effect-of-hsd3b1-1245c-gene-mutation-on-treatment-of-stage-i-iii-breast-cancer-26510https://curecurrent.com/trials/acute-and-long-term-cardiovascular-toxicity-after-modern-radiotherapy-for-breast-cancer-26511https://curecurrent.com/trials/paclitaxel-albumin-stabilized-nanoparticle-formulation-in-treating-patients-of-different-ages-with-metastatic-breast-can-26512https://curecurrent.com/trials/the-role-of-stereo-tactic-body-radiotherapy-in-oligo-progressive-malignant-disease-26513https://curecurrent.com/trials/a-study-to-evaluate-concurrent-vrp-her2-vaccination-and-pembrolizumab-for-patients-with-breast-cancer-26514https://curecurrent.com/trials/identification-of-genetic-determinants-for-treatment-resistance-sensitivity-and-or-toxicity-in-adjuvant-setting-for-her2-26515https://curecurrent.com/trials/evaluation-of-vaginal-microbiome-as-a-biomarker-for-the-improvement-of-vaginal-health-in-women-with-breast-cancer-arise-26516https://curecurrent.com/trials/zap-it-zn-c3-carboplatin-pembrolizumab-in-mtnbc-26517https://curecurrent.com/trials/the-lymph-trial-microsurgical-versus-conservative-treatment-of-chronic-breast-cancer-associated-lymphedema-26518https://curecurrent.com/trials/pilot-study-on-the-clinical-efficacy-of-focused-ultrasound-mediated-targeted-drug-delivery-system-combined-with-neoadjuv-26519https://curecurrent.com/trials/safety-of-lower-scalp-cooling-temperature-to-prevent-hair-loss-from-chemotherapy-in-breast-cancer-patients-26520https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-a-caffeine-based-antifibrosis-cream-in-patients-with-breast-cancer-undergoing-radiat-26521https://curecurrent.com/trials/fertility-preservation-using-tamoxifen-and-letrozole-in-estrogen-sensitive-tumors-trial-26522https://curecurrent.com/trials/memory-perception-assessment-in-central-non-central-nervous-system-cancers-26523https://curecurrent.com/trials/alpelisib-inos-inhibitor-nab-paclitaxel-in-patients-with-her2-negative-metaplastic-breast-cancer-mpbc-26524https://curecurrent.com/trials/late-scan-time-point-optimalisation-of-18f-fluoroestradiol-for-the-large-field-of-view-lafov-pet-ct-scanner-26525https://curecurrent.com/trials/a-study-of-attention-and-memory-processes-in-breast-cancer-survivors-26526https://curecurrent.com/trials/propranolol-and-pembrolizumab-for-tumor-re-sensitization-and-treatment-of-patients-with-checkpoint-inhibitor-refractory-26527https://curecurrent.com/trials/investigation-of-drug-drug-interaction-of-ritonavir-and-itraconazole-on-the-pharmacokinetics-of-shr-a1811-in-subjects-wi-26528https://curecurrent.com/trials/a-study-of-the-impact-of-endocrine-therapy-on-surgical-outcomes-in-people-with-lobular-breast-cancer-26529https://curecurrent.com/trials/a-study-of-bl-m07d1-combined-with-pertuzumab-versus-docetaxel-plus-trastuzumab-and-pertuzumab-in-patients-with-first-lin-26530https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-morab-202-herein-referred-to-as-farletuzumab-ecteribulin-a-f-26531https://curecurrent.com/trials/breast-cancer-education-to-prisoner-women-26532https://curecurrent.com/trials/clinical-information-and-biospecimen-collection-from-patients-with-recurrent-or-stage-iv-breast-cancer-26533https://curecurrent.com/trials/evaluation-of-the-efficacy-of-a-physical-therapy-yoga-patient-educational-program-for-breast-cancer-patients-with-pain-d-26534https://curecurrent.com/trials/a-prospective-multicenter-phase-ii-clinical-study-of-postoperative-chemotherapy-combined-with-ql1706-for-high-risk-tripl-26535https://curecurrent.com/trials/impact-of-the-intraoperative-use-of-amines-in-breast-cancer-surgery-on-tumor-recurrence-26536https://curecurrent.com/trials/tqb2930-injection-for-the-treatment-of-her2-positive-advanced-breast-cancer-26537https://curecurrent.com/trials/the-idea-study-individualized-decisions-for-endocrine-therapy-alone-26538https://curecurrent.com/trials/ethnic-differences-in-the-impact-of-breast-cancer-on-employment-status-financial-situation-and-quality-of-life-26539https://curecurrent.com/trials/sac-tmt-combined-with-bevacizumab-in-tnbc-with-brain-metastases-26540https://curecurrent.com/trials/evaluating-the-implementation-of-a-comprehensive-multilevel-virtual-oncology-program-among-veterans-diagnosed-with-lung-26541https://curecurrent.com/trials/super-resolution-ultrasound-imaging-for-assessing-response-to-neoadjuvant-chemotherapy-in-breast-cancer-26542https://curecurrent.com/trials/generation-of-heart-muscle-cells-from-blood-or-skin-cells-of-breast-cancer-patients-26543https://curecurrent.com/trials/omission-of-surgery-for-triple-negative-breast-cancer-in-complete-response-after-neoadjuvant-chemo-immunotherapy-26544https://curecurrent.com/trials/intraoperative-electron-beam-radiotherapy-boost-in-treating-patients-with-stage-i-ii-breast-cancer-undergoing-surgery-wi-26545https://curecurrent.com/trials/study-of-radiation-exposure-and-bilateral-breast-cancer-26546https://curecurrent.com/trials/phase-1-study-of-clr-125-in-triple-negative-breast-cancer-26547https://curecurrent.com/trials/multimodal-imaging-with-fapi-pet-mri-in-breast-carcinoma-in-situ-for-detection-of-occult-invasive-cancer-26548https://curecurrent.com/trials/a-deep-learning-method-to-evaluate-qt-on-ribociclib-26549https://curecurrent.com/trials/peer-support-for-young-adult-women-with-high-breast-cancer-risk-26550https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-chemotherapy-induced-peripheral-neuropathy-in-breast-and-gynecologic-cancer-surviv-26551https://curecurrent.com/trials/study-of-the-impact-of-dpd-activity-on-the-efficacy-of-capecitabine-26552https://curecurrent.com/trials/visr-ultrasound-for-noninvasively-interrogating-stromal-collagen-organization-in-women-as-a-breast-cancer-biomarker-eval-26553https://curecurrent.com/trials/postoperative-outcomes-and-patient-satisfaction-with-mayo-clinic-florida-care-hotel-after-mastectomy-and-tissue-expander-26554https://curecurrent.com/trials/active-drainage-vs-passive-drainage-in-mrm-26555https://curecurrent.com/trials/the-effects-of-light-therapy-to-treat-cancer-related-side-effects-26556https://curecurrent.com/trials/outcomes-among-patients-in-brazil-receiving-palbociclib-combinations-for-hr-her2-mbc-26557https://curecurrent.com/trials/a-study-of-changes-in-ki67-expression-in-people-with-breast-cancer-receiving-endocrine-therapy-before-surgery-26558https://curecurrent.com/trials/intravital-microscopy-in-human-solid-tumors-26559https://curecurrent.com/trials/flash-breast-evaluating-the-efficacy-of-fezolinetant-in-reducing-vasomotor-symptoms-in-women-with-breast-cancer-on-endoc-26560https://curecurrent.com/trials/the-effect-of-walking-and-grounding-in-women-with-breast-cancer-26561https://curecurrent.com/trials/an-early-stress-reduction-intervention-in-patients-with-newly-diagnosed-breast-cancer-26562https://curecurrent.com/trials/treatment-patterns-and-clinical-outcomes-among-patients-receiving-palbociclib-combinations-for-hormone-receptor-positive-26563https://curecurrent.com/trials/a-study-to-evluate-efficacy-and-safety-of-hrs-8080-combined-with-dalpiciclib-in-patients-with-advanced-or-metastatic-bre-26564https://curecurrent.com/trials/strategies-to-decentralize-breast-ultrasound-in-rwanda-26565https://curecurrent.com/trials/her2-targeted-molecular-imaging-in-mbc-and-other-metastatic-solid-carcinomas-using-68ga-abs011-26566https://curecurrent.com/trials/a-study-to-learn-about-the-dangers-linked-to-myelosuppression-decreased-bone-marrow-function-in-breast-cancer-patients-t-26567https://curecurrent.com/trials/research-on-the-development-and-validation-of-personalized-exercise-prescriptions-for-breast-cancer-patients-based-on-la-26568https://curecurrent.com/trials/a-study-to-learn-about-how-medicines-called-cdk4-6-inhibitors-are-used-in-people-with-advanced-or-metastatic-breast-canc-26569https://curecurrent.com/trials/treatment-pathway-of-patients-suffering-from-a-breast-cancer-related-lymphoedema-26570https://curecurrent.com/trials/post-market-evaluation-of-lumisystem-intraoperative-margin-performance-and-clinical-utility-impact-registry-26571https://curecurrent.com/trials/rejoin-trial-for-older-breast-cancer-survivors-26572https://curecurrent.com/trials/pro1107-in-patients-with-advanced-solid-tumors-26573https://curecurrent.com/trials/study-of-janx008-in-subjects-with-advanced-or-metastatic-solid-tumor-malignancies-26574https://curecurrent.com/trials/prognostic-and-predictive-role-of-intrinsic-molecular-subtypes-in-brca-associated-breast-cancer-26575https://curecurrent.com/trials/3d-ultrasound-breast-imaging-26576https://curecurrent.com/trials/efficacy-and-safety-of-culmerciclib-plus-aromatase-inhibitors-in-a-response-adapted-neoadjuvant-strategy-for-highly-prol-26577https://curecurrent.com/trials/divitum-tka-a-biomarker-assay-for-efficacy-in-hr-breast-cancer-patients-26578https://curecurrent.com/trials/a-phase-ll-interventional-single-arm-study-evaluating-the-efficacy-and-safety-of-inavolisib-plus-ribociclib-and-fulvestr-26579https://curecurrent.com/trials/evaluation-of-wellbeing-and-patient-reported-outcomes-after-open-vs-robotic-mastectomy-with-diep-reconstruction-26580https://curecurrent.com/trials/evaluation-of-the-safety-and-efficacy-of-treatment-w-high-dose-melphalan-given-directly-into-the-liver-followed-by-treat-26581https://curecurrent.com/trials/a-phase-ii-study-of-zongertinib-plus-fulvestrant-in-participants-with-hr-positive-her2-negative-advanced-breast-cancer-h-26582https://curecurrent.com/trials/breast-cancer-screening-adherence-for-women-at-moderate-risk-for-breast-cancer-26583https://curecurrent.com/trials/evaluating-the-de-escalation-of-surveillance-for-patients-who-have-undergone-curative-treatment-for-primary-breast-cance-26584https://curecurrent.com/trials/substantially-improving-the-cure-rate-of-high-risk-brca1-like-breast-cancer-26585https://curecurrent.com/trials/streamlined-geriatric-and-oncological-evaluation-based-on-ic-technology-26586https://curecurrent.com/trials/predicting-breast-cancer-with-the-brave-system-26587https://curecurrent.com/trials/endoscopic-video-assisted-nipple-sparing-mastectomy-26588https://curecurrent.com/trials/phase-i-iia-study-of-68ganota-anti-mmr-vhh2-for-pet-ct-26589https://curecurrent.com/trials/fovinaciclib-plus-aromatase-inhibitors-and-dual-her2-blockade-in-a-response-adapted-neoadjuvant-strategy-for-hr-positive-26590https://curecurrent.com/trials/exercise-therapy-and-cognitive-behavioural-therapy-for-fatigue-in-female-cancer-patients-in-singapore-26591https://curecurrent.com/trials/testing-the-drug-atezolizumab-or-placebo-with-usual-therapy-in-first-line-her2-positive-metastatic-breast-cancer-26592https://curecurrent.com/trials/efficacy-and-safety-of-camizestrant-plus-ribociclib-in-patients-with-breast-cancer-26593https://curecurrent.com/trials/a-phase-1-trial-of-erx-315-in-participants-with-advanced-solid-tumors-26594https://curecurrent.com/trials/pilot-breast-dedicated-pet-camera-with-1-millimeter-spatial-resolution-26595https://curecurrent.com/trials/breast-cancer-relapsed-in-patients-treated-with-adjuvant-cdk4-6-inhibitors-26596https://curecurrent.com/trials/a-study-of-olaparib-and-pembrolizumab-in-people-with-triple-negative-breast-cancer-tnbc-or-hormone-receptor-positive-her-26597https://curecurrent.com/trials/improving-muslim-women-s-uptake-of-cancer-screening-imcan-26598https://curecurrent.com/trials/different-resistance-training-intensity-prescription-and-monitoring-methodologies-effects-on-strength-body-composition-a-26599https://curecurrent.com/trials/preoperative-indocyanine-green-lymphography-and-high-frequency-ultrasound-as-predictors-of-lymphaticovenous-anastomosis-26600https://curecurrent.com/trials/exploration-of-dalpiciclib-chidamide-in-hr-her2-advanced-breast-cancer-after-failure-of-cdk4-6-inhibitor-a-phase-b-study-26601https://curecurrent.com/trials/pyrotinib-and-trastuzumab-combined-with-dalpiciclib-versus-combined-with-docetaxel-in-advanced-her2-positive-breast-canc-26602https://curecurrent.com/trials/developing-screening-clinical-breast-examination-implementation-strategies-in-nigeria-26603https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-preliminary-antitumor-activity-of-inv-6452-in-adult-pat-26604https://curecurrent.com/trials/breast-cancer-survivorship-biorepository-26605https://curecurrent.com/trials/phase-ii-study-of-neoadjuvant-aromatase-inhibitor-therapy-for-er-breast-cancer-naomi-26606https://curecurrent.com/trials/blood-and-image-guided-optimization-of-neoadjuvant-therapy-in-people-with-early-stage-triple-negative-breast-cancer-the-26607https://curecurrent.com/trials/fudan-university-shanghai-cancer-center-breast-cancer-precision-platform-series-study-neoadjuvant-therapy-26608https://curecurrent.com/trials/evaluating-harms-and-benefits-of-endocrine-therapy-in-patients-70-years-of-age-with-lower-risk-breast-cancer-26609https://curecurrent.com/trials/a-study-of-abemaciclib-and-radiation-therapy-in-people-with-metastatic-breast-cancer-26610https://curecurrent.com/trials/testing-the-combination-of-the-anti-cancer-drugs-xl184-cabozantinib-and-nivolumab-in-patients-with-advanced-cancer-and-h-26611https://curecurrent.com/trials/effect-of-low-intensity-vibration-liv-on-aromatase-inhibitor-induced-musculoskeletal-dysfunction-in-early-stage-breast-c-26612https://curecurrent.com/trials/rna-disruption-assay-rda-breast-cancer-response-evaluation-for-individualized-therapy-26613https://curecurrent.com/trials/identification-of-chemotherapy-induced-peripheral-neuropathy-26614https://curecurrent.com/trials/apbi-re-irradiation-26615https://curecurrent.com/trials/srg-514-administered-intraoperatively-to-patients-undergoing-breast-conserving-cancer-surgery-26616https://curecurrent.com/trials/a-study-to-assess-clbr001-abbv-461-in-subjects-with-locally-advanced-or-metastatic-breast-cancer-26617https://curecurrent.com/trials/dalpiciclib-anti-her2-therapy-and-endocrine-therapy-for-hormone-receptor-positive-her2-positive-metastatic-breast-cancer-26618https://curecurrent.com/trials/a-phase-1-study-of-hrs8807-monotherapy-and-in-combination-with-shr6390-in-subjects-with-er-positive-her2-negative-metast-26619https://curecurrent.com/trials/effects-of-tirzepatide-on-blood-imaging-and-breast-tissue-biomarkers-26620https://curecurrent.com/trials/impact-of-formulation-change-on-ovarian-suppression-in-young-breast-cancer-patients-26621https://curecurrent.com/trials/creating-opportunities-for-personal-empowerment-cope-in-women-with-breast-cancer-during-first-line-therapy-a-pilot-rando-26622https://curecurrent.com/trials/elacestrant-in-advanced-triple-positive-breast-cancer-26623https://curecurrent.com/trials/video-conferenced-stress-management-and-relaxation-training-vsmart-for-alabama-breast-cancer-survivors-26624https://curecurrent.com/trials/restoring-metabolic-flexibility-through-combined-exercise-in-breast-cancer-survivors-a-randomized-controlled-trial-26625https://curecurrent.com/trials/the-effect-of-nurse-led-coaching-program-on-self-care-agency-and-quality-of-life-in-reconstructed-breast-cancer-patients-26626https://curecurrent.com/trials/holistic-acupuncture-for-patients-with-chemotherapy-induced-nausea-26627https://curecurrent.com/trials/nadunolimab-in-combination-with-gemcitabine-plus-carboplatin-in-patients-with-advanced-triple-negative-breast-cancer-26628https://curecurrent.com/trials/the-effect-of-nerve-blocks-on-analgesia-in-breast-cancer-surgery-26629https://curecurrent.com/trials/evolution-of-the-therapeutic-care-in-metastatic-breast-cancer-from-2008-26630https://curecurrent.com/trials/adding-surgery-and-radiation-to-the-usual-treatment-for-her2-positive-breast-cancer-that-had-already-spread-at-diagnosis-26631https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-relative-bioavailability-and-food-effect-of-hrs-8080-in-healthy-subjects-26632https://curecurrent.com/trials/a-phase-i-open-label-multi-center-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-azd6244-arry-142886-26633https://curecurrent.com/trials/89zr-dfo-trastuzumab-pet-in-patients-with-gastric-or-breast-cancer-a-pilot-study-26634https://curecurrent.com/trials/minimal-invasive-breast-cancer-excision-using-vacuum-assisted-biopsy-under-ultrasound-guidance-26635https://curecurrent.com/trials/comparison-of-different-methods-of-capture-of-circulating-tumour-cells-ctc-in-patients-with-metastatic-breast-or-prostat-26636https://curecurrent.com/trials/performance-of-diffusion-weighted-imaging-based-virtual-mr-elastography-vmre-for-diagnosing-breast-cancer-26637https://curecurrent.com/trials/dynamic-and-test-retest-whole-body-18f-fes-pet-imaging-in-patients-with-metastatic-er-breast-cancer-26638https://curecurrent.com/trials/gdc-0084-in-combination-with-trastuzumab-for-patients-with-her2-positive-breast-cancer-brain-metastases-26639https://curecurrent.com/trials/oncoplastic-surgery-outcomes-database-26640https://curecurrent.com/trials/cairnsurgical-breast-cancer-locator-bcl-post-market-study-26641https://curecurrent.com/trials/the-value-of-time-dependent-diffusion-mri-and-magnetic-resonance-elastography-in-the-precise-diagnosis-and-efficacy-asse-26642https://curecurrent.com/trials/yl202-versus-treatment-of-physician-s-choice-in-patients-with-hr-her2-breast-cancer-26643https://curecurrent.com/trials/chemotherapy-de-escalation-in-hr-her2-intermediate-risk-early-breast-cancer-treated-with-adjuvant-ribociclib-26644https://curecurrent.com/trials/evaluation-of-a-patient-centered-decision-making-support-tool-for-older-adults-with-advanced-breast-cancer-and-their-car-26645https://curecurrent.com/trials/impact-of-omitting-chemo-based-on-patient-s-selection-for-er-positive-her2-negative-breast-cancer-with-ribociclib-and-en-26646https://curecurrent.com/trials/evaluating-an-evidence-based-family-history-screening-program-adapted-to-increase-reach-and-uptake-of-screening-for-brca-26647https://curecurrent.com/trials/study-of-a-shortened-radiation-therapy-schedule-in-people-with-breast-cancer-26648https://curecurrent.com/trials/probiotics-for-abemaciclib-induced-abdominal-discomfort-26649https://curecurrent.com/trials/abemaciclib-or-abemaciclib-and-hydroxychloroquine-to-target-minimal-residual-disease-in-breast-cancer-26650https://curecurrent.com/trials/oral-vinorelbine-or-capecitabine-combined-with-trastuzumab-as-adjuvant-treatment-for-patients-with-lymph-node-negative-h-26651https://curecurrent.com/trials/personalised-neoantigen-targeting-cancer-vaccine-necvax-neo1-in-neoadjuvant-triple-negative-breast-cancer-26652https://curecurrent.com/trials/a-digital-health-intervention-to-improve-symptoms-and-physical-activity-during-breast-radiation-26653https://curecurrent.com/trials/assessment-of-the-effect-of-probiotic-supplementation-on-proinflammatory-mechanisms-induced-by-systemic-treatment-in-wom-26654https://curecurrent.com/trials/compare-adjuvant-monotherapy-with-endocrine-or-accelerated-partial-breast-irradiation-after-lumpectomy-26655https://curecurrent.com/trials/lymphovenous-bypass-procedure-before-underarm-lymph-node-surgery-in-preventing-lymphedema-in-patients-with-inflammatory-26656https://curecurrent.com/trials/radiation-therapy-followed-by-intrathecal-trastuzumab-pertuzumab-in-her2-breast-leptomeningeal-disease-26657https://curecurrent.com/trials/polarized-light-therapy-for-radiation-dermatitis-in-breast-cancer-26658https://curecurrent.com/trials/prospective-multicentric-study-evaluating-the-surgical-treatment-by-mastectomy-with-immediate-prosthetic-breast-reconstr-26659https://curecurrent.com/trials/clinical-trial-of-atezolizumab-with-paclitaxel-trastuzumab-and-pertuzumab-in-patients-with-metastatic-her-2-positive-bre-26660https://curecurrent.com/trials/a-study-of-u3-1402-patritumab-deruxtecan-in-subjects-with-metastatic-breast-cancer-26661https://curecurrent.com/trials/screening-contrast-enhanced-mammography-as-an-alternative-to-mri-26662https://curecurrent.com/trials/tas102-in-patients-with-er-positive-her2-negative-advanced-breast-cancer-26663https://curecurrent.com/trials/study-to-evaluate-biomarkers-and-safety-of-dapagliflozin-concomitant-with-neoadjuvant-therapy-26664https://curecurrent.com/trials/efficacy-of-transcutaneous-auricular-vagus-nerve-stimulation-tavns-in-aromatase-inhibitor-induced-arthralgia-aia-26665https://curecurrent.com/trials/investigating-datopotamab-deruxtecan-plus-durvalumab-versus-datopotamab-deruxtecan-in-patients-with-pdl1-negative-metast-26666https://curecurrent.com/trials/efficacy-and-safety-of-500mg-of-fulvestrant-26667https://curecurrent.com/trials/saci-nivo-rela-for-tnbc-26668https://curecurrent.com/trials/prospective-surveillance-for-breast-cancer-related-lymphedema-26669https://curecurrent.com/trials/rutgers-university-study-of-the-genetics-of-breast-cancer-26670https://curecurrent.com/trials/writing-interventions-in-breast-cancer-patients-taking-aromatase-inhibitors-26671https://curecurrent.com/trials/clinical-and-biological-study-of-early-onset-breast-cancer-and-the-influence-of-the-reproductive-cycle-on-the-aggressive-26672https://curecurrent.com/trials/identifying-underserved-individuals-intexas-with-hereditary-cancer-risk-using-mobile-mammography-units-and-telegenetics-26673https://curecurrent.com/trials/a-phase-i-interventional-open-label-non-randomized-dose-escalation-trial-to-evaluate-the-safety-tolerability-pharmacokin-26674https://curecurrent.com/trials/sequence-of-endocrine-therapy-in-advanced-luminal-breast-cancer-sequel-breast-26675https://curecurrent.com/trials/veliparib-and-carboplatin-in-treating-patients-with-her2-negative-metastatic-breast-cancer-26676https://curecurrent.com/trials/a-study-of-bb-1701-in-previously-treated-participants-with-human-epidermal-growth-factor-receptor-2-her2-positive-or-her-26677https://curecurrent.com/trials/a-study-of-ly4101174-in-participants-with-recurrent-advanced-or-metastatic-solid-tumors-26678https://curecurrent.com/trials/evaluation-of-sympathetic-skin-response-and-its-relationship-with-clinical-response-to-complex-decongestive-therapy-in-p-26679https://curecurrent.com/trials/vaccination-with-flt3l-radiation-and-poly-iclc-26680https://curecurrent.com/trials/queen-apple-a-single-arm-multicenter-prospective-phase-ii-clinical-study-of-iparomlimab-and-tuvonralimab-ql1706-in-combi-26681https://curecurrent.com/trials/ar-health-education-video-for-postoperative-breast-cancer-patients-26682https://curecurrent.com/trials/phase-ib-ii-clinical-study-of-qls1304-combined-with-endocrine-therapy-in-the-treatment-of-er-her2-breast-cancer-patients-26683https://curecurrent.com/trials/chemotherapy-induced-peripheral-neuropathy-additional-evaluation-in-breast-cancer-survivors-26684https://curecurrent.com/trials/efficacy-of-trastuzumab-deruxtecan-in-metastatic-breast-cancer-with-different-her2-expression-patterns-26685https://curecurrent.com/trials/phase-0-master-protocol-for-civo-intratumoral-microdosing-of-anti-cancer-therapies-26686https://curecurrent.com/trials/on-treatment-single-cell-analysis-for-the-identification-of-early-tumor-response-biomarkers-on-prospective-collected-ser-26687https://curecurrent.com/trials/ln-145-or-ln-145-s1-in-treating-patients-with-relapsed-or-refractory-ovarian-cancer-triple-negative-breast-cancer-tnbc-a-26688https://curecurrent.com/trials/research-on-the-whole-process-intelligent-diagnosis-and-treatment-of-digital-breast-tomosynthesis-based-on-deep-learning-26689https://curecurrent.com/trials/pilot-observational-study-of-an-integrative-cure-stay-program-26690https://curecurrent.com/trials/video-education-with-result-dependent-disclosure-26691https://curecurrent.com/trials/ixabepilone-in-treating-participants-with-significant-residual-disease-of-her2-neu-negative-invasive-breast-cancer-after-26692https://curecurrent.com/trials/a-phase-iii-trial-comparing-hrs-8080-with-standard-endocrine-therapy-in-patients-with-intermediate-or-high-risk-early-br-26693https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-efficacy-and-safety-of-hlx319-vs-eu-phesgo-in-the-neoadjuvant-therapy-of-her2-p-26694https://curecurrent.com/trials/adjuvant-endocrine-therapy-adherence-intervention-pilot-in-rwanda-26695https://curecurrent.com/trials/a-master-trial-assessing-the-technical-feasibility-of-first-in-human-real-time-image-guided-radiation-therapy-methods-26696https://curecurrent.com/trials/ls301-it-in-partial-mastectomy-and-sentinel-lymph-node-biopsy-slnb-for-dcis-or-stage-i-ii-primary-invasive-breast-cancer-26697https://curecurrent.com/trials/a-registry-for-people-with-t-cell-lymphoma-26698https://curecurrent.com/trials/effects-of-a-pilates-studio-program-on-quality-of-life-and-functional-capacity-of-women-undergoing-breast-cancer-treatme-26699https://curecurrent.com/trials/abemaciclib-dose-escalation-in-early-high-risk-breast-cancer-adjuvant-therapy-26700https://curecurrent.com/trials/safety-pharmacokinetics-pharmacodynamics-and-preliminary-efficacy-of-mt-304-in-adults-with-advanced-her2-expressing-soli-26701https://curecurrent.com/trials/contrast-free-magnetic-resonance-imaging-for-breast-disease-26702https://curecurrent.com/trials/cemiplimab-and-transarterial-radioembolization-with-y-90-sir-s-spheres-for-the-treatment-of-liver-directed-metastatic-br-26703https://curecurrent.com/trials/comparing-whole-brain-radiotherapy-using-a-technique-that-avoids-the-hippocampus-to-stereotactic-radiosurgery-in-patient-26704https://curecurrent.com/trials/a-long-term-follow-up-study-of-participants-treated-with-a2-biotherapeutics-a2-bio-gene-therapy-gt-products-26705https://curecurrent.com/trials/multi-center-mrd-registry-for-inflammatory-breast-cancer-26706https://curecurrent.com/trials/locoregional-treatment-and-palbociclib-in-de-novo-treatment-naive-stage-iv-er-her2-breast-cancer-patients-26707https://curecurrent.com/trials/endocrine-therapy-plus-cdk4-6-in-first-or-second-line-for-hormone-sonia-receptor-positive-advanced-breast-cancer-26708https://curecurrent.com/trials/a-phase-ii-study-of-neoadjuvant-sacituzumab-govitecan-and-pembrolizumab-therapy-for-immunochemotherapy-resistant-early-s-26709https://curecurrent.com/trials/role-of-axillary-lymph-node-dissection-for-residual-macrometastases-after-neoadjuvant-chemotherapy-in-patients-with-her2-26710https://curecurrent.com/trials/a-web-based-program-kindred-to-improve-the-understanding-of-genetic-cancer-risk-and-cancer-genetic-testing-in-african-am-26711https://curecurrent.com/trials/learn-learning-environment-for-artificial-intelligence-in-radiotherapy-new-technology-26712https://curecurrent.com/trials/effect-of-web-based-nursing-navigator-programme-on-breast-cancer-screening-behaviors-in-women-at-high-risk-of-breast-can-26713https://curecurrent.com/trials/stress-management-and-biological-age-in-breast-cancer-patients-rct-26714https://curecurrent.com/trials/arm-exercise-capacity-and-maximal-oxygen-consumption-with-breast-cancer-26715https://curecurrent.com/trials/responses-to-genetic-risk-modifier-testing-among-women-with-pathogenic-variants-in-breast-cancer-predisposition-genes-26716https://curecurrent.com/trials/diversity-and-inclusion-in-research-underpinning-prevention-and-therapy-trials-26717https://curecurrent.com/trials/understanding-and-addressing-rejection-of-personalized-breast-cancer-risk-information-in-women-26718https://curecurrent.com/trials/18f-ftt-positron-emission-tomography-for-the-measurement-of-parp-tumor-expression-in-patients-with-metastatic-breast-can-26719https://curecurrent.com/trials/a2-eso-1-tcr-engineered-t-cells-for-relapsed-refractory-advanced-or-metastatic-ny-eso-1-overexpression-positive-triple-n-26720https://curecurrent.com/trials/concurrent-wokvac-vaccination-chemotherapy-and-her2-targeted-monoclonal-antibody-therapy-before-surgery-for-the-treatmen-26721https://curecurrent.com/trials/effectiveness-of-surgery-for-improving-survival-in-oligometastatic-breast-cancer-patients-26722https://curecurrent.com/trials/enhancing-skin-appearance-and-quality-of-life-in-breast-cancer-survivors-on-aromatase-inhibitor-therapy-26723https://curecurrent.com/trials/hybr-d-educat-on-based-on-psychodynam-c-nurs-ng-theory-of-women-undergo-ng-mastectomy-26724https://curecurrent.com/trials/accelerated-partial-breast-irradiation-with-imrt-in-early-breast-cancer-26725https://curecurrent.com/trials/self-management-interventions-to-reduce-cardiovascular-risks-in-breast-cancer-survivors-26726https://curecurrent.com/trials/arm-swelling-occurence-in-breast-cancer-patients-with-nodal-radiotherapy-impact-of-informing-them-of-ai-predicted-risk-26727https://curecurrent.com/trials/ultrasound-monitoring-of-clipped-lymph-nodes-to-predict-axillary-response-after-chemotherapy-in-breast-cancer-26728https://curecurrent.com/trials/eras-protocols-in-breast-conserving-surgery-26729https://curecurrent.com/trials/study-of-pf-07220060-with-letrozole-in-adults-with-hr-positive-her2-negative-breast-cancer-who-have-not-received-antican-26730https://curecurrent.com/trials/phase-3-study-of-gedatolisib-as-first-line-treatment-for-patients-with-hr-positive-her2-negative-advanced-breast-cancer-26731https://curecurrent.com/trials/the-computerized-retraining-and-functional-treatment-group-intervention-26732https://curecurrent.com/trials/study-of-the-safety-of-mri-scans-in-people-who-have-breast-tissue-expanders-after-mastectomy-26733https://curecurrent.com/trials/identifying-ideal-reimbursement-dose-to-reduce-clinical-trial-related-financial-toxicity-26734https://curecurrent.com/trials/impact-of-web-application-support-versus-standard-management-on-compliance-with-adjuvant-hormone-therapy-at-18-months-in-26735https://curecurrent.com/trials/genetic-pathological-studies-of-brca1-brca2-associated-tumors-blood-samples-26736https://curecurrent.com/trials/education-with-or-without-exercise-and-counseling-in-preventing-lymphedema-in-women-with-stage-i-stage-ii-or-stage-iii-b-26737https://curecurrent.com/trials/atop-trial-t-dm1-in-her2-positive-breast-cancer-26738https://curecurrent.com/trials/transcutaneous-electrical-nerve-stimulation-in-chemotherapy-induced-peripheral-neuropathy-in-patients-with-stage-i-iii-e-26739https://curecurrent.com/trials/the-comparison-between-dedti-br-and-t-e-br-26740https://curecurrent.com/trials/breast-cancer-survivors-reset-reducing-weight-and-elevated-stress-levels-using-educational-and-behavioral-tools-a-pilot-26741https://curecurrent.com/trials/clinical-application-of-vagus-nerve-stimulation-combined-with-immunoregulatory-t-cells-in-alleviating-aromatase-inhibito-26742https://curecurrent.com/trials/fatlas-comprehensive-multi-level-characterization-of-systemic-and-mammary-adiposity-in-breast-cancer-patients-26743https://curecurrent.com/trials/expander-based-versus-direct-to-implant-pre-pectoral-breast-reconstruction-a-comparative-analysis-of-surgical-outcomes-26744https://curecurrent.com/trials/her2-positive-metastatic-breast-cancer-in-kazakhstan-26745https://curecurrent.com/trials/hypofractionated-radiation-therapy-in-treating-participants-with-breast-cancer-before-surgery-26746https://curecurrent.com/trials/neoadjuvant-concomitant-modulated-electro-hyperthermia-in-her2-negative-breast-cancer-26747https://curecurrent.com/trials/a-study-of-limited-heart-monitoring-during-non-anthracycline-trastuzumab-based-therapy-in-breast-cancer-patients-26748https://curecurrent.com/trials/detection-of-cancer-in-breath-samples-by-trained-detection-dogs-26749https://curecurrent.com/trials/a-clinical-investigation-to-confirm-the-ability-of-mammowave-in-breast-lesions-detection-26750https://curecurrent.com/trials/bevacizumab-and-temsirolimus-alone-or-in-combination-with-valproic-acid-or-cetuximab-in-treating-patients-with-advanced-26751https://curecurrent.com/trials/neoadjuvant-study-of-hifu-with-or-without-pd-1-inhibitors-followed-by-abraxane-plus-carboplatin-in-triple-negative-breas-26752https://curecurrent.com/trials/a-study-of-trastuzumab-deruxtecan-t-dxd-versus-trastuzumab-emtansine-t-dm1-in-high-risk-her2-positive-participants-with-26753https://curecurrent.com/trials/effect-of-daflon-diosmin-and-hesperidin-on-post-operative-seroma-formation-in-breast-cancer-surgery-26754https://curecurrent.com/trials/frozen-section-examination-of-sentinel-lymph-nodes-in-breast-cancer-26755https://curecurrent.com/trials/neoadjuvant-trastuzumab-pertuzumab-plus-metronomic-vinorelbine-for-elderly-her2-positive-breast-cancer-26756https://curecurrent.com/trials/identification-of-breast-cancer-in-breath-samples-using-trained-detection-dogs-26757https://curecurrent.com/trials/pregnancy-outcomes-after-breast-cancer-in-young-women-with-germline-pathogenic-variants-in-genes-other-than-brca-26758https://curecurrent.com/trials/emerald-endocrine-therapy-omission-with-radiation-in-er-breast-cancer-assessing-quality-of-life-and-disease-control-a-pr-26759https://curecurrent.com/trials/evaluating-the-effectiveness-of-aromatherapy-for-alleviating-distress-in-breast-cancer-patients-before-radiotherapy-26760https://curecurrent.com/trials/5t4-targeting-nanobody-probe-for-pet-imaging-in-solid-tumors-26761https://curecurrent.com/trials/survival-monitoring-in-russian-cancer-registries-26762https://curecurrent.com/trials/promoting-resilience-in-women-with-breast-cancer-prism-mbc-26763https://curecurrent.com/trials/non-invasive-detection-of-breast-cancer-by-breath-analysis-26764https://curecurrent.com/trials/trastuzumab-in-treating-women-with-metastatic-breast-cancer-26765https://curecurrent.com/trials/impact-of-propranolol-strategies-on-myocardial-injury-after-breast-cancer-surgery-26766https://curecurrent.com/trials/trastuzumab-rezetecan-t-dxh-in-her2-breast-cancer-with-non-pcr-after-tcbhp-26767https://curecurrent.com/trials/phase-iii-trial-of-brain-mri-surveillance-in-stage-iv-breast-cancer-26768https://curecurrent.com/trials/a-study-of-yl202-in-patients-with-locally-advanced-or-metastatic-non-small-cell-lung-cancer-and-breast-cancer-26769https://curecurrent.com/trials/a-study-of-dato-dxd-versus-investigator-s-choice-chemotherapy-in-patients-with-locally-recurrent-inoperable-or-metastati-26770https://curecurrent.com/trials/the-sarah-nanotechnology-system-for-treatment-of-advanced-metastatic-solid-tumors-using-hyperthermia-26771https://curecurrent.com/trials/biology-guided-therapy-recommendations-for-treatment-determination-of-hormone-receptor-positive-advanced-unresectable-or-26772https://curecurrent.com/trials/neoadjuvant-toripalimab-plus-docetaxel-and-carboplatin-in-patients-with-localized-tnbc-neotop-26773https://curecurrent.com/trials/the-association-of-lunula-status-with-the-efficacy-and-safety-of-neoadjuvant-therapy-in-breast-cancer-26774https://curecurrent.com/trials/elacestrant-and-exemestane-for-patients-with-pretreated-hr-her2-metastatic-breast-cancer-and-18f-fes-avid-lesions-combin-26775https://curecurrent.com/trials/patient-relevant-outcomes-improvement-program-in-high-risk-hormone-receptor-positive-hr-breast-cancer-26776https://curecurrent.com/trials/hepatitis-c-screening-paired-with-mammography-26777https://curecurrent.com/trials/testing-the-feasibility-of-a-virtual-application-to-support-breast-and-colorectal-cancer-survivors-26778https://curecurrent.com/trials/a-study-of-palbociclib-pd-0332991-letrozole-vs-placebo-letrozole-for-1st-line-treatment-of-asian-postmenopausal-women-wi-26779https://curecurrent.com/trials/cascade-testing-in-families-with-newly-diagnosed-hereditary-breast-and-ovarian-cancer-syndrome-26780https://curecurrent.com/trials/a-study-of-lerociclib-in-participants-with-advanced-breast-cancer-26781https://curecurrent.com/trials/a-study-of-blood-pressure-control-during-cancer-treatment-26782https://curecurrent.com/trials/real-world-treatment-of-adc-resistant-her2-low-advanced-breast-cancer-26783https://curecurrent.com/trials/neoadjuvant-and-adjuvant-ribociclib-and-et-for-clinically-high-risk-er-and-her2-breast-cancer-26784https://curecurrent.com/trials/neoadjuvant-dupilumab-pembrolizumab-paclitaxel-and-carboplatin-in-locally-advanced-triple-negative-breast-cancer-26785https://curecurrent.com/trials/tumour-cell-response-to-acute-aerobic-exercise-in-breast-cancer-survivors-modulatory-effects-of-exercise-type-and-intens-26786https://curecurrent.com/trials/a-study-of-surgery-and-radiotherapy-in-people-with-breast-cancer-26787https://curecurrent.com/trials/johns-hopkins-breast-cancer-program-longitudinal-repository-26788https://curecurrent.com/trials/18f-t2-pet-ct-imaging-for-caix-positive-solid-tumors-26789https://curecurrent.com/trials/a-study-of-changes-in-thinking-related-to-aging-and-cancer-in-breast-cancer-survivors-trac-26790https://curecurrent.com/trials/romiplostim-n01-plus-atra-for-persistent-isolated-chemotherapy-induced-thrombocytopenia-after-complete-remission-of-gyne-26791https://curecurrent.com/trials/heart-health-after-cancer-treatment-heart-act-26792https://curecurrent.com/trials/exploring-the-feasibility-of-an-exercise-and-noninvasive-brain-stimulation-intervention-in-breast-cancer-survivors-26793https://curecurrent.com/trials/the-dialogue-study-swiss-korean-billateral-collaboration-26794https://curecurrent.com/trials/cognitive-impairment-assessment-in-breast-cancer-survivors-26795https://curecurrent.com/trials/exbrac-expressive-writing-in-breast-cancer-26796https://curecurrent.com/trials/neoadjuvant-ql1706-in-patients-with-hormone-receptor-positive-her2-negative-breast-cancer-26797https://curecurrent.com/trials/the-association-between-axillary-lymph-node-metastasis-patterns-and-breast-cancer-prognosis-26798https://curecurrent.com/trials/development-of-new-methodologies-and-innovative-tools-for-the-diagnosi-and-therapeutic-treatment-of-umani-epithelial-tum-26799https://curecurrent.com/trials/rc48-adc-in-her2-low-advanced-breast-cancer-26800https://curecurrent.com/trials/impact-of-genetic-variants-on-the-toxicity-of-antibody-drug-conjugates-in-locally-advanced-or-metastatic-breast-cancer-t-26801https://curecurrent.com/trials/dance-intervention-in-breast-cancer-treatment-26802https://curecurrent.com/trials/the-association-between-blood-routine-parameters-and-breast-cancer-prognosis-26803https://curecurrent.com/trials/core-biopsies-for-establishing-a-breast-tumor-tissue-repository-26804https://curecurrent.com/trials/cascade-genetic-testing-for-hereditary-breast-ovarian-cancer-and-lynch-syndrome-in-switzerland-26805https://curecurrent.com/trials/effects-of-aerobic-exercise-on-cancer-related-biomarkers-functional-capacity-cognitive-status-and-quality-of-life-in-wom-26806https://curecurrent.com/trials/biospecimen-collection-in-identifying-genetic-changes-in-patients-with-breast-prostate-colorectal-liver-or-kidney-cancer-26807https://curecurrent.com/trials/shoulder-denervation-for-post-mastectomy-irradiation-shoulder-pain-26808https://curecurrent.com/trials/brodalumab-in-the-treatment-of-immune-related-adverse-events-26809https://curecurrent.com/trials/a-novel-therapy-for-breast-cancer-survivors-with-genitourinary-syndrome-of-menopause-26810https://curecurrent.com/trials/a-clinical-investigation-to-evaluate-microwave-imaging-via-mammowave-in-a-population-based-screening-program-for-early-b-26811https://curecurrent.com/trials/effects-of-moderate-intensity-interval-aerobic-exercise-miiae-on-inflammatory-immune-metabolic-physical-fitness-and-qual-26812https://curecurrent.com/trials/al18f-her2-bch-pet-in-breast-patients-treated-with-adc-therapy-26813https://curecurrent.com/trials/personalized-detection-of-ctdna-for-patients-with-her2-positive-metastatic-breast-cancer-patients-who-achieved-durable-r-26814https://curecurrent.com/trials/her2heart-us-prevention-of-cardiotoxicity-in-breast-cancer-patients-receiving-her2-directed-therapy-26815https://curecurrent.com/trials/gim27-therapy-a-study-to-describe-the-effectiveness-of-tucatinib-in-combination-with-capecitabine-and-trastuzumab-in-the-26816https://curecurrent.com/trials/neoadjuvant-serplulimab-plus-weekly-paclitaxel-and-carboplatin-in-tnbc-neo-serpent-26817https://curecurrent.com/trials/emulation-of-the-monaleesa-2-trial-using-specialty-oncology-electronic-health-records-databases-26818https://curecurrent.com/trials/avocado-consumption-and-cellular-aging-in-breast-cancer-survivors-26819https://curecurrent.com/trials/adjuvant-palbociclib-in-elderly-patients-with-breast-cancer-26820https://curecurrent.com/trials/a-phase-ii-biomarker-trial-of-gelatin-encapsulated-extract-of-american-ginseng-root-leag-in-breast-cancer-26821https://curecurrent.com/trials/comparing-an-operation-to-monitoring-with-or-without-endocrine-therapy-comet-trial-for-low-risk-dcis-26822https://curecurrent.com/trials/global-cardio-oncology-registry-26823https://curecurrent.com/trials/start-safety-and-anti-tumor-activity-of-pepticrad-1-in-treatment-of-cancer-26824https://curecurrent.com/trials/emulation-of-the-monarch-3-trial-using-specialty-oncology-electronic-health-records-databases-26825https://curecurrent.com/trials/a-prospective-study-using-implanted-fiducial-markers-to-assess-treatment-accuracy-and-esophageal-toxicity-in-spinal-ster-26826https://curecurrent.com/trials/follow-up-in-early-and-locally-advanced-breast-cancer-patients-26827https://curecurrent.com/trials/assessing-women-s-attitudes-about-the-risk-of-infertility-related-to-adjuvant-therapy-for-early-breast-cancer-26828https://curecurrent.com/trials/male-breast-cancer-understanding-the-biology-for-improved-patient-care-26829https://curecurrent.com/trials/developing-breast-cancer-organoids-26830https://curecurrent.com/trials/a-study-to-investigate-the-effect-of-food-on-the-bioavailability-of-oral-paclitaxel-administered-with-encequidar-in-part-26831https://curecurrent.com/trials/super-resolution-ultrasound-microvascular-mapping-for-non-invasive-breast-cancer-molecular-subtyping-a-validated-nomogra-26832https://curecurrent.com/trials/emulation-of-the-paloma-2-trial-26833https://curecurrent.com/trials/individual-factors-associated-with-care-pathways-delays-in-breast-cancer-in-hauts-de-france-26834https://curecurrent.com/trials/effect-of-kinesio-taping-and-laser-therapy-in-patient-with-lymphedema-on-girth-measurement-26835https://curecurrent.com/trials/study-of-paclitaxel-polymeric-micelles-combined-with-hp-and-adebelimab-versus-taxane-combined-with-hp-as-first-line-trea-26836https://curecurrent.com/trials/efficacy-and-safety-of-dalpiciclib-combined-with-endocrine-adjuvant-therapy-for-early-hr-her2-breast-cancer-a-multicente-26837https://curecurrent.com/trials/estradiol-in-treating-patients-with-er-beta-positive-triple-negative-locally-advanced-or-metastatic-breast-cancer-26838https://curecurrent.com/trials/enzalutamide-and-paclitaxel-before-surgery-in-treating-patients-with-stage-i-iii-androgen-receptor-positive-triple-negat-26839https://curecurrent.com/trials/refusal-of-sentinel-lymph-node-biopsy-in-patients-with-luminal-a-subtype-early-breast-cancer-26840https://curecurrent.com/trials/multidisciplinary-team-intervention-in-cardio-oncology-titan-study-26841https://curecurrent.com/trials/ribociclib-tucatinib-and-trastuzumab-for-the-treatment-of-her2-positive-breast-cancer-26842https://curecurrent.com/trials/shared-decision-making-for-patients-with-her2-negative-metastatic-breast-cancer-sdm-01-26843https://curecurrent.com/trials/living-with-chronic-cancer-treatments-longeviti-study-26844https://curecurrent.com/trials/effects-of-exercise-in-patients-with-metastatic-breast-cancer-26845https://curecurrent.com/trials/a-patient-navigation-intervention-for-the-improvement-of-risk-management-among-women-at-high-risk-of-breast-cancer-26846https://curecurrent.com/trials/the-t-rex-trial-tailored-regional-external-beam-radiotherapy-in-clinically-node-negative-breast-cancer-patients-with-1-2-26847https://curecurrent.com/trials/a-low-insulinemic-dietary-intervention-to-reduce-breast-cancer-risk-in-high-risk-women-26848https://curecurrent.com/trials/ablative-sbrt-in-elderly-bc-patients-26849https://curecurrent.com/trials/comparison-of-serratus-posterior-superior-intercostal-plane-block-and-rhomboid-intercostal-block-in-patients-undergoing-26850https://curecurrent.com/trials/a-trial-of-trastuzumab-rezetecan-in-unresectable-locally-recurrent-metastatic-breast-cancer-26851https://curecurrent.com/trials/breast-cancer-navigate-prospective-cohort-26852https://curecurrent.com/trials/supplemental-screening-for-women-with-extremely-dense-breast-tissue-the-dense-2-trial-26853https://curecurrent.com/trials/adj-marker-adjusted-personalized-therapy-comparing-et-ribociclib-vs-chemotherapy-in-intermediate-risk-hr-her2-ebc-26854https://curecurrent.com/trials/evaluate-the-implementation-of-using-indocyanine-green-for-sentinel-lymph-node-mapping-in-breast-cancer-patients-26855https://curecurrent.com/trials/a-randomized-self-controlled-post-marketing-clinical-study-on-the-comparison-of-shengbai-oral-liquid-and-leucogen-tablet-26856https://curecurrent.com/trials/a-dose-escalation-expansion-study-of-oral-op-1250-in-subjects-with-advanced-and-or-metastatic-hr-her2-breast-cancer-26857https://curecurrent.com/trials/registry-of-patients-undergoing-cryoablation-for-early-stage-breast-cancer-26858https://curecurrent.com/trials/study-of-skb264-for-locally-advanced-recurrent-or-metastatic-hr-her2-breast-cancer-26859https://curecurrent.com/trials/feasibility-of-a-lifestyle-intervention-for-women-with-triple-negative-breast-cancer-under-neoadjuvant-immunotherapy-26860https://curecurrent.com/trials/a-study-of-a166-in-patients-with-her2-positive-unresectable-or-metastatic-breast-cancer-26861https://curecurrent.com/trials/a-study-of-skb264-versus-investigator-s-choice-of-chemotherapy-in-subjects-with-unresectable-locally-advanced-relapsed-o-26862https://curecurrent.com/trials/testing-ado-trastuzumab-emtansine-as-a-potential-targeted-treatment-in-cancers-with-her2-genetic-changes-match-subprotoc-26863https://curecurrent.com/trials/chemotherapy-induced-cognitive-impairment-26864https://curecurrent.com/trials/bundled-cancer-screening-and-genetic-services-navigation-26865https://curecurrent.com/trials/preoperative-irradiation-for-stage-i-breast-cancer-26866https://curecurrent.com/trials/t-dxd-therapy-for-her2-low-breast-cancer-patients-with-brain-metastases-26867https://curecurrent.com/trials/molecular-subtyping-of-breast-cancer-derived-small-extracellular-vesicles-sevs-to-predict-therapeutic-efficacy-26868https://curecurrent.com/trials/impact-of-consumption-of-ultra-processed-foods-in-individuals-at-high-risk-of-cancer-26869https://curecurrent.com/trials/a-study-of-a166-versus-trastuzumab-emtansine-t-dm1-in-patients-with-her2-positive-unresectable-or-metastatic-breast-canc-26870https://curecurrent.com/trials/sac-tmt-plus-kl-a167-in-pd-l1-hr-her2-metastatic-breast-cancer-after-cdk4-6-inhibitors-26871https://curecurrent.com/trials/investigate-the-contribution-of-ipatasertib-to-neoadjuvant-chemotherapy-plus-atezolizumab-in-tnbc-26872https://curecurrent.com/trials/a-multilevel-approach-to-connecting-underrepresented-populations-to-clinical-trials-26873https://curecurrent.com/trials/the-effect-of-video-assisted-mindfulness-based-breathing-on-quality-of-life-and-mental-well-being-in-individuals-with-br-26874https://curecurrent.com/trials/impact-of-ketogenic-diet-on-tumor-microenvironment-in-patients-with-breast-cancer-26875https://curecurrent.com/trials/a-phase-i-ii-trial-of-ucb4594-in-participants-with-advanced-cancer-26876https://curecurrent.com/trials/a-study-of-skb264-versus-investigator-s-choice-chemotherapy-in-patients-with-unresectable-recurrent-or-metastatic-triple-26877https://curecurrent.com/trials/skb264-injection-vs-investigator-selected-regimens-to-treat-locally-advanced-recurrent-or-metastatic-triple-negative-bre-26878https://curecurrent.com/trials/pilot-study-of-68ga-ga-aby-025-imaging-in-patients-undergoing-treatment-with-her2-targeted-therapy-26879https://curecurrent.com/trials/elacestrant-in-women-and-men-with-cdk4-6-inhibitor-naive-estrogen-receptor-positive-her-2-negative-metastatic-breast-can-26880https://curecurrent.com/trials/vocational-rehabilitation-for-the-return-to-work-of-breast-cancer-patients-a-feasibility-study-26881https://curecurrent.com/trials/piloting-y-ambient-a-quality-of-life-intervention-for-young-african-american-breast-cancer-survivors-26882https://curecurrent.com/trials/lymphedema-surveillance-study-26883https://curecurrent.com/trials/liquid-biopsy-informed-platform-trial-to-evaluate-cdk4-6-inhibitor-resistant-er-her2-metastatic-breast-cancer-26884https://curecurrent.com/trials/prospective-randomized-study-of-accelerated-radiation-therapy-prart-26885https://curecurrent.com/trials/nerve-mobilization-techniques-after-breast-cancer-surgery-26886https://curecurrent.com/trials/biopsy-of-calcifications-under-contrast-enhancement-guide-bocce-26887https://curecurrent.com/trials/sentinel-lymph-node-biopsy-versus-no-axillary-surgery-in-early-breast-cancer-26888https://curecurrent.com/trials/proteomics-and-radiomics-research-of-breast-cancer-markers-in-tissue-interstitial-fluid-and-serum-26889https://curecurrent.com/trials/comparison-of-low-dose-spiral-breast-ct-with-mri-in-major-indications-of-mri-for-breast-diagnostics-26890https://curecurrent.com/trials/quilt-2-025-nant-neoepitope-yeast-vaccine-ye-neo-001-adjuvant-immunotherapy-using-a-personalized-neoepitope-yeast-based-26891https://curecurrent.com/trials/evaluating-and-monitoring-immune-and-clinical-responses-in-early-stage-triple-negative-breast-cancer-undergoing-neoadjuv-26892https://curecurrent.com/trials/contrast-enhancement-mammography-vs-mri-for-the-surveillance-of-women-at-high-risk-of-breast-cancer-con-trust-randomized-26893https://curecurrent.com/trials/post-market-safety-study-of-lumisight-26894https://curecurrent.com/trials/evaluating-the-de-escalation-of-surveillance-for-patients-who-have-undergone-curative-treatment-for-breast-cancer-26895https://curecurrent.com/trials/the-phocus-trial-implementation-of-pharmacogenomic-testing-in-oncology-care-26896https://curecurrent.com/trials/cool-it-pro-cryoablation-of-breast-cancer-in-non-surgical-patients-26897https://curecurrent.com/trials/omission-of-slnb-in-triple-negative-and-her2-positive-breast-cancer-patients-with-rcr-and-pcr-in-the-breast-after-nast-26898https://curecurrent.com/trials/microrna-profiles-in-triple-negative-breast-cancer-26899https://curecurrent.com/trials/ultrasound-guided-core-needle-biopsy-to-assess-sensitivity-and-specificity-of-axillary-lymph-node-metastasis-in-breast-c-26900https://curecurrent.com/trials/targeting-stress-driven-inflammatory-and-angiogenic-pathways-with-brief-act-to-enhance-neoadjuvant-chemotherapy-response-26901https://curecurrent.com/trials/ice-plant-intensive-cream-for-the-prevention-of-hand-foot-syndrome-in-breast-cancer-pilot-randomized-controlled-trial-26902https://curecurrent.com/trials/neocard-anthracycline-free-neoadjuvant-chemoimmunotherapy-in-triple-negative-breast-cancer-patients-26903https://curecurrent.com/trials/cancer-of-the-breast-asanas-study-cobra-26904https://curecurrent.com/trials/single-fraction-accelerated-partial-breast-irradiation-vs-five-fraction-accelerated-partial-breast-irradiation-for-low-r-26905https://curecurrent.com/trials/targeted-next-generation-sequencing-panel-for-identification-of-germline-mutations-in-early-onset-cancers-with-sporadic-26906https://curecurrent.com/trials/temporal-immunologic-changes-with-hypofractionated-radiation-induced-dna-damage-in-breast-cancer-26907https://curecurrent.com/trials/impact-trial-intervention-to-improve-adherence-equitably-26908https://curecurrent.com/trials/pilot-study-of-bone-mineral-density-changes-during-anti-pd-1-immunotherapy-26909https://curecurrent.com/trials/concurrent-vs-sequential-adjuvant-treatments-in-early-breast-cancer-26910https://curecurrent.com/trials/trial-of-neoadjuvant-thp-vs-tchp-for-her2-amplified-positive-breast-cancer-26911https://curecurrent.com/trials/preventing-breast-cancer-therapy-related-cardiovascular-toxicity-with-a-daily-adapted-program-with-mhealth-support-26912https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-pf-07248144-in-combination-with-fulvestrant-in-people-with-hr-positive-26913https://curecurrent.com/trials/utilizing-continuous-glucose-monitoring-to-characterize-and-manage-hyperglycemia-in-patients-initiating-alpelisib-26914https://curecurrent.com/trials/evaluation-of-talazoparib-a-parp-inhibitor-in-patients-with-somatic-brca-mutant-metastatic-breast-cancer-genotyping-base-26915https://curecurrent.com/trials/dose-escalation-and-dose-expansion-study-of-mdx2001-in-patients-with-advanced-solid-tumors-26916https://curecurrent.com/trials/evaluation-of-cognitive-education-activities-in-breast-cancer-patients-receiving-chemotherapy-26917https://curecurrent.com/trials/memantine-and-exercise-to-improve-cognitive-function-and-modulate-biological-pathways-of-cognitive-decline-during-chemot-26918https://curecurrent.com/trials/doxorubicin-hydrochloride-and-cyclophosphamide-followed-by-paclitaxel-with-or-without-carboplatin-in-treating-patients-w-26919https://curecurrent.com/trials/testing-sacituzumab-govitecan-therapy-in-patients-with-her2-negative-breast-cancer-and-brain-metastases-26920https://curecurrent.com/trials/pf-07104091-as-a-single-agent-and-in-combination-therapy-26921https://curecurrent.com/trials/pancreatic-cancer-genetics-26922https://curecurrent.com/trials/pi-targeted-pne-mi-compared-to-biomedical-education-in-bcs-26923https://curecurrent.com/trials/aim-3-adapting-and-implementing-evidence-based-breast-cancer-follow-up-in-primary-care-26924https://curecurrent.com/trials/evaluating-the-safety-and-efficacy-of-a-novel-accelerated-partial-breast-irradiation-regimen-26925https://curecurrent.com/trials/fezolinetant-for-the-improvement-of-vasomotor-symptoms-in-breast-cancer-patients-taking-endocrine-therapy-vent-trial-26926https://curecurrent.com/trials/altering-lipids-for-tolerance-of-aromatase-inhibitor-therapy-26927https://curecurrent.com/trials/i-spy-trial-neoadjuvant-and-personalized-adaptive-novel-agents-to-treat-breast-cancer-26928https://curecurrent.com/trials/opioid-free-anaesthesia-in-breast-cancer-surgery-26929https://curecurrent.com/trials/testing-gdc-0032-taselisib-as-a-potential-targeted-treatment-in-cancers-with-pik3ca-genetic-changes-match-subprotocol-i-26930https://curecurrent.com/trials/a-quality-of-life-intervention-for-young-african-american-breast-cancer-survivors-in-treatment-26931https://curecurrent.com/trials/window-study-of-intratumoral-mitazalimab-in-breast-cancer-winit-bc-26932https://curecurrent.com/trials/efficacy-and-safety-of-sph4336-in-combination-with-endocrine-therapy-in-breast-cancer-patients-with-brain-metastases-26933https://curecurrent.com/trials/pagetex-photodynamic-therapy-device-for-the-treatment-of-extra-mammary-paget-s-disease-of-the-vulva-empv-26934https://curecurrent.com/trials/cisplatin-vs-doxorubicin-cyclophosphamide-in-brca-26935https://curecurrent.com/trials/geriatric-care-survivorship-intervention-for-improving-the-overall-health-of-older-adults-with-stage-i-iii-breast-cancer-26936https://curecurrent.com/trials/study02001740-22sch740-estradiol-for-er-advanced-breast-cancer-esther-26937https://curecurrent.com/trials/wish-feasibility-of-a-factorial-design-26938https://curecurrent.com/trials/evaluation-in-the-treatment-of-neuropathic-pain-post-breast-surgery-26939https://curecurrent.com/trials/mri-in-assessing-tumor-size-in-women-with-ductal-carcinoma-in-situ-26940https://curecurrent.com/trials/axelopran-for-advanced-cancer-in-patients-receiving-opioids-26941https://curecurrent.com/trials/implementation-study-to-describe-and-compare-retention-rate-and-adherence-to-adjuvant-therapy-with-ribociclib-with-and-w-26942https://curecurrent.com/trials/unified-barlow-protocol-up-in-cancer-survivors-for-cognitive-impairments-26943https://curecurrent.com/trials/intraoperative-electron-radiotherapy-for-low-risk-early-breast-cancer-26944https://curecurrent.com/trials/non-contrast-dwi-for-supplemental-screening-26945https://curecurrent.com/trials/characterization-of-innate-immune-system-in-patients-with-luminal-advanced-breast-cancer-26946https://curecurrent.com/trials/study-aiming-to-compare-the-plasma-exposure-of-the-payload-free-dxd-in-patients-treated-by-t-dxd-for-locally-advanced-or-26947https://curecurrent.com/trials/randomized-feasibility-trial-for-mesh-in-pre-pectoral-reconstruction-26948https://curecurrent.com/trials/predicting-response-to-capecitabine-in-women-with-metastatic-breast-cancer-26949https://curecurrent.com/trials/prospective-study-of-vegfr-2-il-8-genetic-interaction-in-mbc-treated-with-paclitaxel-and-bevacizumab-vs-chemotherapy-26950https://curecurrent.com/trials/three-fraction-accelerated-partial-breast-irradiation-as-the-sole-method-of-radiation-therapy-for-low-risk-stage-0-and-i-26951https://curecurrent.com/trials/determining-the-extent-of-the-genitourinary-syndrome-of-menopause-burden-in-breast-cancer-survivors-26952https://curecurrent.com/trials/levobupivacaine-and-lidocaine-for-paravertebral-block-causes-greater-hemodynamic-oscillations-than-levobupivacaine-26953https://curecurrent.com/trials/digital-peer-navigation-for-adolescents-and-young-adults-with-cancer-26954https://curecurrent.com/trials/her3-dxd-in-breast-cancer-and-nsclc-brain-metastases-and-solid-tumor-leptomeningeal-disease-26955https://curecurrent.com/trials/a-physical-activity-program-to-improve-quality-of-life-and-reduce-fatigue-in-metastatic-breast-cancer-26956https://curecurrent.com/trials/phase-ii-study-of-ultrasound-and-ctdna-guided-neoadjuvant-systemic-therapy-for-patients-with-her2-positive-early-breast-26957https://curecurrent.com/trials/study-of-lp-184-in-patients-with-advanced-solid-tumors-26958https://curecurrent.com/trials/atezolizumab-sacituzumab-govitecan-to-prevent-recurrence-in-tnbc-aspria-26959https://curecurrent.com/trials/efficacy-and-safety-of-pembrolizumab-mk-3475-plus-lenvatinib-e7080-mk-7902-in-previously-treated-participants-with-selec-26960https://curecurrent.com/trials/genetic-testing-for-all-breast-cancer-patients-get-facts-26961https://curecurrent.com/trials/multiparametric-mri-for-assessing-breast-cancer-response-to-anti-her2-therapy-26962https://curecurrent.com/trials/personalized-patient-derived-xenograft-ppdx-modeling-to-test-drug-response-in-matching-host-26963https://curecurrent.com/trials/motor-cognitive-training-effects-on-cognition-in-breast-cancer-survivors-the-brainonfit-study-brainonfit-26964https://curecurrent.com/trials/adding-a-genetic-risk-evaluation-to-standard-breast-cancer-risk-assessment-for-african-american-and-hispanic-women-26965https://curecurrent.com/trials/treatment-of-breast-fibroadenoma-targeted-tissue-with-hifu-26966https://curecurrent.com/trials/feasibility-and-acceptibility-of-a-multi-site-trial-of-time-restircted-eating-during-chemotheraply-for-breast-cancer-26967https://curecurrent.com/trials/role-of-pcgem1-in-breast-cancer-26968https://curecurrent.com/trials/concurrent-neoadjuvant-chemo-endocrine-therapy-in-her2-breast-cancer-26969https://curecurrent.com/trials/neutrophil-extracellular-traps-formation-in-breast-cancer-patients-taking-tamoxifen-26970https://curecurrent.com/trials/the-role-of-prolonged-nightly-fasting-to-improve-sleep-and-cognition-in-breast-cancer-survivors-26971https://curecurrent.com/trials/to-evaluate-the-effectiveness-and-safety-of-mastectomy-combined-with-immediate-breast-reconstruction-in-breast-cancer-nj-26972https://curecurrent.com/trials/radiation-therapy-in-treating-patients-with-stage-0-ii-breast-cancer-26973https://curecurrent.com/trials/ctdna-positive-patients-diagnosed-with-ct1bn0-and-ct1cn0-tnbc-26974https://curecurrent.com/trials/phase-ii-trial-evaluating-the-safety-and-efficacy-of-the-combination-of-zimberelimab-domvanalimab-and-sacituzumab-govite-26975https://curecurrent.com/trials/tailored-axillary-surgery-with-or-without-axillary-lymph-node-dissection-followed-by-radiotherapy-in-patients-with-clini-26976https://curecurrent.com/trials/alpelisib-and-sacituzumab-govitecan-for-treatment-of-breast-cancer-26977https://curecurrent.com/trials/detection-and-outcomes-in-metastatic-invasive-lobular-breast-cancer-through-novel-f-18-fap-pet-26978https://curecurrent.com/trials/effect-of-continuous-erector-spinae-plane-block-with-ropivacaine-on-postoperative-pain-and-nf-b-levels-after-mastectomy-26979https://curecurrent.com/trials/comparison-of-axillary-sentinel-lymph-node-biopsy-versus-no-axillary-surgery-26980https://curecurrent.com/trials/interventional-program-educates-identifies-overcomes-barriers-to-complete-screening-mammography-26981https://curecurrent.com/trials/shorter-course-radiation-for-the-treatment-of-breast-cancer-that-has-spread-to-lymph-nodes-26982https://curecurrent.com/trials/decision-aid-for-women-newly-diagnosed-with-breast-cancer-26983https://curecurrent.com/trials/a-study-of-ak138d1-alone-or-in-combination-with-ivonescimab-in-advanced-breast-cancer-26984https://curecurrent.com/trials/effect-of-foot-reflexology-on-chemotherapy-induced-nausea-and-vomiting-in-breast-cancer-patients-26985https://curecurrent.com/trials/preoperative-sleep-quality-and-postoperative-outcomes-in-breast-surgery-26986https://curecurrent.com/trials/sodium-glucose-transporter-type-2-inhibition-in-anthracycline-related-cardiotoxicity-26987https://curecurrent.com/trials/a-study-of-9mw2821-versus-chemotherapy-in-participants-with-previously-treated-locally-advanced-or-metastatic-triple-neg-26988https://curecurrent.com/trials/achieving-equity-in-genomic-testing-for-breast-cancer-through-partner-led-strategies-and-policies-26989https://curecurrent.com/trials/effect-of-patient-anesthesiologist-gender-concordance-and-analgesia-method-on-postoperative-pain-in-mastectomy-patients-26990https://curecurrent.com/trials/capivasertib-fulvestrant-vs-placebo-fulvestrant-as-treatment-for-locally-advanced-inoperable-or-metastatic-hr-her2-breas-26991https://curecurrent.com/trials/brain-radiotherapy-combined-with-dalpiciclib-and-endocrine-therapy-in-hr-positive-her2-negative-advanced-breast-cancer-w-26992https://curecurrent.com/trials/comparative-effectiveness-trial-of-two-supportive-cancer-care-delivery-models-for-adults-with-cancer-26993https://curecurrent.com/trials/pregnancy-and-fertility-registry-26994https://curecurrent.com/trials/hemodynamic-effects-of-intradermal-methylene-blue-during-breast-surgery-under-general-anesthesia-26995https://curecurrent.com/trials/ilr-to-prevent-brcl-mcc-23608-26996https://curecurrent.com/trials/combination-chemotherapy-with-or-without-fluorouracil-and-or-pegfilgrastim-in-treating-women-with-node-positive-breast-c-26997https://curecurrent.com/trials/the-embrace-study-the-embrace-study-26998https://curecurrent.com/trials/vs-6766-abema-fulv-in-met-hr-her-bc-26999https://curecurrent.com/trials/a-2-week-ketogenic-diet-in-combination-with-letrozole-to-modulate-pi3k-signaling-in-er-breast-cancer-27000